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The experiments presented in this thesis are aimed at better understanding the ion and drug 
permeation properties of the mechano-electrical transduction (MET) channels of the hair cells 
responsible for hearing. Aminoglycosides (AGs) are potent antibiotics prescribed worldwide in 
the treatment of gram-negative infections such as sepsis, neonatal infections, and those 
associated with cystic fibrosis. AGs permeate into hair cells of the inner ear via the MET channels, 
which are large, non-selective mechanosensitive cation channels at the tips of the stereocilia. 
Once inside, AGs cause death of hair cells with varying degrees of severity depending on the 
drug family member and location of the cell along the length of the cochlea, with basal outer 
hair cells (OHCs) dying more readily than apical OHCs and inner hair cells (IHCs). By 
experimentally modelling the interaction between the MET channel and drugs that block it, we 
can determine electrical properties of the channel and calculate entry rates of the drugs into the 
cells. I present evidence for a correlation between the toxicity of three AGs (gentamicin, 
kanamycin and amikacin) and their entry rate through the MET channel in OHCs, with 
gentamicin being the most readily permeable and amikacin being the least. Furthermore, I have 
found that all four drugs (including the fluorescently conjugated gentamicin-Texas Red) that I 
have modelled permeate at a higher rate through individual channels in basal OHCs than those 
in apical OHCs.  I have also probed the roles of calcium, maturation, and driving force in drug 
permeation, and addressed aspects of the genetics of the channel and how these may relate to 
our model. Lastly, I present evidence for the existence of volume-regulated anion channels 














ASIC Acid-sensing ion channel 
AG Aminoglycoside antibiotic 
b Relative distance of the binding site 
CDH23 Cadherin 23 
E Difference in energy barriers 
DHS Dihydrostreptomycin 
E1  First energy barrier 
E2  Second energy barrier 
Eb Free energy of the binding site 
GTTR Gentamicin-Texas Red 
k1 Forward rate over the first energy barrier 
KD Half-blocking concentration 
IHC Inner hair cell 
MET Mechano-electrical transducer 
nH Hill coefficient 
OHC Outer hair cell 
P Postnatal day 
PCDH1  Protocadherin 15 
RVD Regulatory volume decrease 
ROI Region of interest 
TMC Transmembrane channel-like 
V0 Voltage of maximum block (calculated) 
Vmax Voltage of maximum block (measured) 
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The peripheral auditory system is an extraordinarily complex and finely tuned apparatus capable 
of detecting signals with impressive fidelity, and it enriches our lives with beautiful sensory 
detail. Our sense of hearing is essential to communication and to the appreciation of music, both 
of which are sources of joy for many. Unfortunately, due to its delicate nature hearing loss can 
easily transpire, and those that experience it often suffer greatly. In fact, hearing loss is 
frequently comorbid with dementia (Uhlmann et al., 1989; Lin and Albert, 2014) indicating an 
essential role in quality of life. Depending on the cause, hearing loss can be irreversible.  
Striving for a better understanding of the synergistic ballet of the peripheral auditory system 
and the mechanisms by which it can be damaged is paramount in the effort to preventing 
hearing loss and deafness in the population.  
 
1.1.1 Transduction of sound to the inner ear 
When something moves (i.e. a car, vocal cords, or the strings on a violin), it generates waves of 
pressure in the atmosphere around it. These waves propagate outward in all directions, and in 
the simplest of terms our ears detect them and relay them to the brain. Sound waves can be 
described in terms of amplitude and frequency, and together these make up a waveform  
(Purves et al., 2018). The simplest waveform is a pure sine wave, which we often use in the lab 
as a stimulus when studying the transduction of sound. Sound waves produced in the 
environment are rarely this simple. Not only do waveforms from different sources add and 
subtract from each other (constructive and destructive interference), but furthermore, what we 
think of as individual notes in a scale are in fact made up of many harmonic overtones—multiples 
of the fundamental tone—characteristic to the instrument that is playing them. These overtones 
sum together to produce distinctive waveforms, and we can use these waveforms to identify 
the sources of sounds—for example, a violin versus a human voice as in figure 1-1. Waveforms 
from multiple sources sum to produce a single, continuous and seemingly random waveform. 
Waveforms can be deconstructed into their composing frequencies by a mathematical process 
called a Fourier transform. Incredibly, the clever arrangement of our peripheral auditory system 
allows it to perform this operation mechanically. The auditory nerve (VIIIth cranial nerve) then 
relays the decomposed signal to the auditory brainstem and cortex for further processing 




As a sound wave arrives at the ear, it is gathered by the pinna and concha—the visible parts of 
the auditory system which are commonly referred to as the ear. In fact, these are only the very 
first part of the structure: the outer ear. In humans, the pinna and concha perform an 
equalisation of the soundscape by passively boosting the sound pressure of frequencies 
between 2 to 5 kHz about 30- to 100-fold (Purves et al., 2018). The pinna and concha also 
selectively filter sounds by their angle of arrival, giving a rough indication of the direction of the 
sound source (Purves et al., 2018). The sound is then funnelled down the ear canal and arrives 
at the entrance to the middle ear: the ear drum, or tympanic membrane. The ear drum is a thin 
membrane that collects the vibrations in air pressure and transfers them down the ossicles of 
the middle ear: the hammer, anvil, and stirrup (malleus, incus and stapes). These are among the 
smallest bones in the human body, and they transmit vibrations from the relatively large ear 
drum onto the much smaller entrance to the inner ear, the oval window of the cochlea.  
This process amplifies the pressure of the signal about 200-fold (Purves et al., 2018). Thus, the 
middle ear performs the first transformation of the signal in the pathway to hearing: matching 
the low-impedance vibrations of air pressure to high-impedance vibrations in fluid pressure 
inside the cochlea (Purves et al., 2018).  
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Inside the skull resides the inner ear, comprising the utricle and semi-circular canals (responsible 
for balance and the sensing of movement), and the cochlea. Figure 1-2 details the components 
of the peripheral auditory system. The cochlea is a coiled bony shell, and it decomposes sounds 
by pitch along its length, analogous to a piano inside the head with high pitches sensed at the 
basal end of the coil and low pitches sensed at the apex (figure 1-3). This property is referred to 
as tonotopy. Along its interior run three fluid-filled compartments: the scala vestibuli, scala 
tympani, and the scala media (figure 1-4). The scala vestibuli and the scala media are separated 
by Reissner’s membrane, and the scala media and scala tympani are separated by the basilar 
membrane. The scala vestibuli and tympani contain perilymph, while the scala media contains 
an unusual medium called endolymph which will be further discussed in section 1.1.3.  
The basilar membrane is key to frequency tuning of the cochlea. It moves in the shape of a 
traveling wave from the base to the apex of the coil, resonating at specific locations along its 
length depending on the frequency (or pitch) of the signal. Within the scala media along the top 
of the basilar membrane, lies the organ of Corti: a collection of highly specialised cells including 










1.1.2 Sensory hair cells 
There are many interesting components of the organ of Corti, problems in any of which can 
contribute to hearing loss. But few are as complex as the hair cells. Along the length of the organ 
are four rows of sensory hair cells; three rows of outer hair cells (OHCs) and one row of inner 
hair cells (IHCs) as illustrated in figure 1-4. This thesis will focus on the OHCs of the mouse.  
OHCs are long, tubular cells atop which sit a V-shaped bundle of stiff, rod-like stereocilia. These 
stereocilia are arranged into three rows ranging from shortest to tallest and are linked together 
at the top by tip links composed of protocadherin-15 (PCDH15) on the lower third and  
cadherin-23 (CDH23) on the upper two thirds (Kazmierczak et al., 2007). The OHC hair bundles 
are embedded in the tectorial membrane, while the IHC hair bundles are generally less organised 
and are probably not directly attached the tectorial membrane (Engström and Engström, 1978). 
At the top of the shorter stereocilia, the tip links of both OHCs and IHCs are anchored to a large 
proprietary nonselective cation channel called the mechano-electrical transducer (MET) 
channel. Deflection of the bundle by a sound wave produces a shearing motion of the stereocilia 
against the tectorial membrane. This puts tension on the tip links and physically pulls open the 
MET channels allowing influx of ions (mainly potassium and calcium) carrying electrical current 
and causes depolarisation of the cell (figure 1-5). The process of mechanotransduction will be 
reviewed in detail in section 1.2.  
OHCs respond to sound by contracting with impressive fidelity in time with the signal, amplifying 
the movement of the basilar membrane (Ashmore, 2008; Dallos, 2008). The change in voltage 
of the OHCs due to opening of the MET channel causes the membrane to contract much like a 
Hoberman sphere (figure 1-5). This property is known as electromotility and is due to activation 
of voltage-sensitive prestin embedded in the OHC membranes (Ashmore, 2008; Dallos, 2008), 
and it can be observed in excised mouse OHCs from about postnatal day 7 (P7) onwards. The 
amplified movement of the fluid under the tectorial membrane is then sensed by the stationary 
IHCs, which transmit the signal to the auditory nerve and up to the brain. Both OHCs and IHCs 
are innervated, though the ratios of each type of innervation are different. While IHCs are 
innervated by about 95% of the afferent neurons (ascending to the brain), OHCs are only 
innervated by the remaining 5% (Purves et al., 2018). Additionally, efferent neurons (descending 
from the brain) innervate the OHCs but their exact function remains unclear. The movement of 
OHCs produces sound called otoacoustic emissions, so it is thought that efferent innervation 
may tune this movement to regulate the stiffness of the basilar membrane (He, 1997; Wersinger 





1.1.4 Gradients in the development of hair cells 
During development of the inner ear, a complicated sequence of gene expression produces a 
smooth gradient in the components of the cochlea. Morphogens diffuse away from one end to 
the other and depending on the threshold of the signal cells will differentiate accordingly. In the 
mouse, the cochlea originates from sensory progenitor cells of the ectoderm on either side of 
the hindbrain (Groves and Fekete, 2012). The earliest marker of the developing inner ear is PAX2, 
which also gives rise to the epidermis (Groves and Fekete, 2012). SOX2 is then expressed in 
multiple pro-sensory patches which will give rise to the three cristae of the semi-circular canals, 
the two maculae of the utricle, and the cochlear epithelium (Bok et al., 2007; Groves et al., 2013). 
The anterior-posterior axis of the inner ear is set up by retinoic acid synthesis on the posterior 
side and degradation on the anterior side (Bok et al., 2011).  
The organ of Corti itself grows out from one point in the pro-sensory domain set up by SOX2. 
Notch patterning differentiates cell fates between hair cells and supporting cells (Batts, 2009). 
ATOH1 is the key hair cell specifier, and its expression begins in the basal cells of the mouse 
cochlea on embryonic day (E) 13.5, progressing towards the apex (Chen et al., 2002; Groves et 
al., 2013). Apical OHCs then mature about five days later than basal OHCs (Groves et al., 2013). 
The regulating factor for this wave of maturation is cyclin-dependent kinase inhibitor P27kip1: 
conditional knock-out of P27kip1 leads to supernumerary proliferation and survival of hair cells 
into adulthood (Walters et al., 2014).  
As well as a difference in the timing of maturity, apical and basal OHCs have morphological 
differences in size and function. The smaller size of the basal cells means a smaller membrane 
capacitance, allowing them to respond to the faster signals of the high frequencies (Johnson et 
al., 2011). Bundle morphology of OHCs changes in the base and apex, with basal bundles starting 
out slightly taller than apical but shortening over the first few postnatal days (Lelli et al., 2009). 
The acquisition of mechanotransduction also occurs in a gradient, with transduction beginning 
in the base at P0 and progressing through to the apex to full completion by P7 (Lelli et al., 2009). 
Recent evidence also shows that the tip links of OHCs demonstrate an increased stiffness in basal 
cells compared to apical (Tobin et al., 2019). Gradients that alter the properties of 
mechanotransduction along the cochlea are numerous, and even occur at the level of the 
conductance and genetic composition of the MET channel itself. 
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1.2 The MET channel and its history 
1.2.1 Biokinetics of the mechanotransduction complex in hair cells 
The MET channel is characterised by a large single-channel conductance of approximately  
100 pS (Pan et al., 2013, Kim et al., 2013, Beurg et al., 2018, Beurg et al., 2019) and ultra-fast 
kinetics of up to 100 kHz (Doll et al., 2012). These properties are essential to the precise and 
faithful transduction of the extremely fast stimulus that is sound, and the way in which the MET 
channel achieves this impressive feat will be summarised here.  
The driving force for current flow through the MET channel is set up by the endocochlear 
potential, a large electrochemical gradient in between the scala media and the scala tympani. 
The endolymph in the scala media contains an unusually high extracellular K+ concentration in 
excess of 150 mM, compared to the 5 mM of the perilymph in the scala tympani (Purves et al., 
2018). This high K+ concentration is generated and actively maintained by the stria vascularis, 
which secretes K+ into the scala media (Tasaki and Spyropoulos, 1959; Purves et al., 2018).  
This difference in ionic composition produces an electrical potential difference of approximately 
+80 mV between the endolymph and the perilymph (Purves et al., 2018). The hair bundle sits in 
the endolymph, whereas the cell body is bathed in perilymph. As the interior of the cell sits 
between -40 and -70 mV relative to the perilymph (Mammano and Ashmore, 1996; Marcotti 
and Kros, 1999; Johnson et al., 2011), this means that there is a gradient of up to +150 mV 
between the endolymph and the hair cell; an absolutely massive amount of pressure pushing 
positively charged ions (and other molecules!) into the cell. Figure 1-5 illustrates the 
environment of an OHC. The endocochlear potential is stronger in the base than the apex of the 
cochlea (Konishi and Mendelsohn, 1970; Guo et al., 2012), further tuning the tonotopic function 
of the hair cells. K+ is cleared from the cells by ion channels in the basolateral membrane 
(Fettiplace, 2017).  
At its narrowest point, the pore of the channel is commonly thought to measure approximately 
12.5 Å, with a mouth width of 17 Å and a total length of 31 Å (Farris et al., 2004). Recent 
permeation studies suggest that this could in fact be a drastic underestimation and that the pore 
can fit larger molecules, including the peptide D-JNKi1 of 15 Å (Desmonds, 2015), and even the 
3 kDa dextran-Texas Red (Ballesteros et al., 2018) of 23 Å (Choi et al., 2010). Permeation of 
fluorescent compounds follows the tonotopic gradient, with basal cells showing stronger 




Early extracellular recordings localised the MET channel to the tops of the stereocilia (Hudspeth, 
1982), and fast confocal imaging confirmed their location at the insertion point of the lower end 
of the tip links (Beurg et al., 2009). The tip links are composed of a handshake between 
protocadherin 15 (PCDH15) and cadherin 23 (CDH23) (Kazmierczak et al., 2007; Goodyear et al. 
2010; Sotomayor et al., 2012; Bartsch et al., 2018). CDH23 is bound to a myosin-motor complex 
on the inside of the taller stereocilia, and PCDH15 contacts the MET channel complex on the top 
of the shorter stereocilia (Beurg et al., 2009). The interaction between CDH23 and PCDH15 is 
calcium-dependent and buffering of calcium with BAPTA or EGTA breaks the tip links and 
abolishes mechanotransduction (Assad et al., 1991; Zhao et al., 1996). During daily life, tip links 
can act as a pressure valve to protect the hair cell. They can be broken by excessively high stimuli, 
but amazingly can regenerate over a period of 24 hours (Zhao et al., 1996; Indzhykulian et al., 
2013). This may be partly to blame for that unpleasant sensation of tinnitus and mild hearing 
loss when you go to bed after a loud gig.  
The MET channel exhibits two types of adaptation, slow and fast, both of which are dependent 
on calcium (Ricci and Fettiplace, 1997; Wu et al., 1999; Ricci, 2002; Corns et al., 2014).  
Fast adaptation happens on the order of a millisecond or faster and is likely due to calcium 
binding either directly to the channel or to the gating spring, reducing the open probability.  
Slow adaptation is more complex and is thought to involve calcium diffusion through the 
stereocilia and affecting the myosin-motor of the tip link attached to the next shortest row. This 
motor is thought to involve myosin VIIa (Kros et al., 2002), which interacts with CDH23 through 
calmodulin (Grati and Kachar, 2011). When calcium binds to calmodulin, it releases the 
interaction and the myosin motor slips down, decreasing the tension in the tip link. It then begins 
to crawl back up, retensioning the tip link and resetting the operation point of the channel 
(Gillespie, 2004; Grati and Kachar, 2011).  
In the absence of stimulation, the channel has a resting open probability of 0.1 to 0.5 (Howard 
and Hudspeth, 1988; Farris et al., 2006; Beurg et al., 2010) indicating that a proportion of 
channels are open at rest. This can be observed as a constant membrane current even while 
blocking basolateral ion channels and can be calculated as a proportion of the maximal MET 
current that can be elicited. The resting current is abolished when a negative stimulus is applied 
to the hair bundles—this releases the proportion of tip links that are under tension at rest, 
closing all the remaining channels. It is thought that there are two or possibly more MET 
channels per stereocilium (Beurg et al., 2006; Fettiplace, 2009; Beurg et al., 2018), though the 
implications of this for the joint gating of multiple permeation pathways, while feasible, are still 
unclear (Sul and Iwasa, 2010; Corey et al., 2019). 
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To achieve its incredibly quick activation time (Doll et al. 2012), the MET channel must be 
physically coupled to the tip link. The gating-spring model was first introduced by Corey and 
Hudspeth in 1983 to account for the observation that activation of MET channels caused a 
reduction in hair bundle stiffness. But experiments using electron microscopy (Kachar et al., 
2000) and molecular dynamics simulations (Sotomayor et al., 2010, Sotomayor et al., 2012, 
Powers et al. 2017) have suggested that the tip links themselves are too stiff to be the gating 
spring, so it is thought there may be another component in the complex that gates the opening 
of the MET channel. Alternatively, the spring could be the membrane itself, as tent-like 
deformations around the insertion point of the tip link have been shown (Powers et al., 2012; 
Reichenbach and Hudsepth, 2014). Either way, differences in adaptation in apex and base (Ricci, 
2002; Ricci et al., 2003) suggest that the stiffness of the gating spring could be dependent on 
intracellular Ca2+ concentration immediately inside the transduction channel (Reichenbach and 
Hudspeth, 2014) and would require a calcium-sensing domain that could bind to and modulate 
the permeation properties of the channel. A recent candidate for this function is CIB2 (Giese et 
al., 2017) which will be discussed in section 1.2.3. 
 
1.2.2 The discovery of the MET channel and its pore-forming subunit 
Mechanically sensitive electrical activity of the hair bundle was first described by Hudspeth and 
Corey in a 1977 publication in PNAS, who subsequently did much early work characterising the 
activity of the MET channel in the bullfrog sacculus (Corey and Hudspeth, 1979; Corey and 
Hudspeth, 1983). MET currents were first recorded in the mouse by Kros et al. in 1992.  
Since, the MET channel has generated huge interest and has been the subject of countless 
publications across the last 3 decades.  
Characterising the channel responsible for these fascinating mechanically-sensitive currents has 
been a challenge to the research community: its study is confounded by the small number of 
channels per hair cell (~100), and the fact that no large-scale hair cell lines exist as of yet. The 
molecular composition of the channel is difficult to tease apart because it is likely a complex of 
several different proteins, and eliminating any single component of the chain can have profound 
effects on its kinetics and even abolish mechanotransduction. Due to the remote location of the 
MET channel relative to the cell body, many proteins are thought to be involved in targeting and 
trafficking of the various MET channel components to the tips of the stereocilia, further 
complicating the issue. It has also been difficult to find high-affinity ligands specific to the 
channel that exist for purification, likely because the channel is assembled at the stereocilia tips 
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(Wu and Muller, 2016). Similarly, it is difficult to image protein localisation at the tips of the 
stereocilia as they are so small, and there is often a build-up of precursor and trafficking proteins 
in the cuticular plate at the insertion point of the stereocilia into the apical surface of the cell 
(Ugawa et al., 2006, Ugawa et al., 2008). 
For many years, the identity of the MET channel was the subject of controversial debate. Several 
candidates have been proposed in the race for the pore-forming subunit, but until recently none 
have been shown to form ion permeation pathways when expressed in cell membrane. Many 
reviews have been published on the subject, including a pair of contrasting articles in 2016 as 
part of the Dual Perspectives series in the Journal of Neuroscience: one by Corey and Holt, and 
the other by Wu and Müller. Until very recently opinions were split over the identity of the pore-
forming subunit, but conclusive evidence was published by Pan et al. in 2018 proving it beyond 
doubt to be the transmembrane channel-like isoforms 1 and 2 (TMC1 and TMC2). The remaining 
subunits of the channel remain inconclusive, however. Other proteins that have been closely 
implicated include LHFPL5, TMIE, CIB2, and ASIC1b (figure 1-7). The evidence for these and their 






1.2.3 Potential MET channel complex candidates (the runners-up for the 
pore) 
LHFPL5 (formerly known as TMHS) causes deafness in mice when mutated and is localised near 
the lower end of the tip links (Xiong et al., 2012). Lhfpl5-/- mutants have up to a 90% reduction 
in mechanotransduction from stepwise deflections of the bundle, and single-channel recordings 
show that the conductance of the MET channel is impaired (Xiong et al., 2012). However, the 
MET channel currents are not fully abolished, which almost definitely excludes LHFPL5 from 
being the pore-forming subunit. LHFPL5 was also shown to regulate the transport of PCDH15 
into stereocilia, thereby potentially controlling the efficiency of tip-link formation (Xiong et al., 
2012). It was later found that LHFPL5 binds to TMC1 and PCDH15, and that TMC1 is no longer 
localised to stereocilia in Lhflp5-/- mutants (Beurg et al., 2015). Structural similarities have been 
shown between LHFPL5 and the TARP subunits of AMPA receptors, which regulate both the 
transport and pore formation of AMPA receptors (Cais et al., 2014). It is possible that LHFPL5 
may be performing a similar role in the MET channel complex (Wu and Müller, 2016).  
Another protein, the aptly named trans-membrane inner ear protein (TMIE) is also linked to 
deafness and localised to the tip links (Gleason et al., 2009, Zhao et al., 2014). Tmie-/- zebrafish 
mutants show degeneration of the hair cells and lack a microphonic response to  
vibration—indicating compromised mechanotransduction (Gleason et al., 2009). In mice,  
Tmie-/- mutants have abnormal mechanotransduction but normal tip link assembly, and acute 
re-expression of TMIE in early postnatal ages can rescue mechanotransduction, indicating that 
it is not solely necessary in development (Zhao et al., 2014). Interestingly, TMIE only binds to 
PCDH15 and not to either TMC1 or TMC2, unlike LHFPL5. In fact, it appears that in the absence 
of TMIE all other known MET channel proteins are correctly targeted, and yet the channel is  
non-functional (Wu and Müller, 2016). TMIE could be supporting another as-yet unknown 
function of the MET channel, or it could potentially bind other channel subunits together.  
The MET channel is permeable to calcium and some of its properties—such as adaptation—are 
modulated by calcium concentrations. It is thought that one or more of the accessory proteins 
of the MET channel may be involved with calcium sensing. The calcium- and integrin-binding 
protein 2 (CIB2) was identified as associated with non-syndromic deafness in humans and was 
recently localised to the tips of the shorter stereocilia (Michel et al., 2017). Cib2 mutation was 
associated with mild disruption of hair bundle formation, followed by profound OHC loss by 
P110 (Giese et al., 2017). This suggests that CIB2 is not essential for the formation of hair bundles 
but does play an essential role in mechanotransduction. In fact, Cib2 mutants showed no uptake 
of FM1-43, a commonly used MET channel-permeable dye (Gale et al., 2001), and whole-cell 
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patch-clamp recordings in the IHCs showed no MET currents. CIB2 was found to form strong 
interactions with both TMC1 and TMC2 (Giese et al., 2017). This places CIB2 quite convincingly 
alongside the MET channel complex, and it is currently suspected that CIB2 may perhaps be a 
calcium sensor for fast adaptation, or even the elusive gating spring (Powers et al., 2012;  
Giese et al., 2017). 
Finally, the acid-sensing ion channel 1b (ASIC1b) has emerged as a potential candidate for an 
accessory to the MET channel complex for several reasons: it has been localised to the stereocilia 
of OHCs (Ugawa et al., 2006); it is likely to be mechanically gated (Ugawa et al., 2008); and it is 
blocked by amiloride (a high blood pressure medication) in the same manner as the MET channel 
complex (Rusch et al., 1994; Ugawa et al., 2008). Though ASIC1b is known to form a mechanically 
sensitive channel (Ugawa et al., 2008), it is unlikely to be the pore-forming subunit of the 
channel complex because Asic1b-/- still elicit a seemingly normal MET current when stimulated. 
A potential role for ASIC1b in the MET channel complex is that it may have a role in proton 
sensing similar to its function in other systems. It could be that ASIC1b is involved with adapting 
the MET channel to changes in extracellular pH during aging (Ugawa et al., 2008). 
Each of these candidates is unlikely the be the pore itself, but they are all clearly intimately 
implicated in the MET channel complex. Their exact contributions to the complex are yet 
unknown. 
 
1.2.4 TMC1 and TMC2 
TMC1 and TMC2 were first identified for their role in hearing loss in a positional cloning study of 
genes involved in deafness (Kurima et al., 2002). More than 35 mutations in Tmc1 cause human 
hearing loss (Kawashima et al., 2011), making it one of the most common deafness genes 
(Fettiplace, 2016). Interestingly, mutations in Tmc2 do not cause deafness (Kurima et al., 2002), 
and the first studies of Tmc1-/- early postnatal mouse mutants were unpromising as they 
exhibited normal MET currents (Marcotti et al., 2006), but it was soon found that these currents 
were abolished from the second postnatal week onward (Kawashima et al., 2011). Furthermore, 
it was found that TMC1 and TMC2 are co-expressed from early development and are functionally 
redundant until TMC2 is downregulated from about P10 (figure 1-4), and that Tmc1-/-/Tmc2-/- 
mutation does in fact completely abolish MET currents (Kawashima et al., 2011; Pan et al., 
2013). It was also found that deletion of Tmc1 and Tmc2 does not alter either the tip links or the 
hair bundle morphology (Kawashima et al., 2011). Fluorescently tagged TMC1 and TMC2 were 
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then successfully localised to the lower end of tip links (Kurima et al., 2015), and it was found 
that both TMC1 and TMC2 form linkages with PCDH15—the lower component of the tip links 
(Maeda et al., 2014, Beurg et al., 2015). A single point mutation called Tmc1Bth/Bth (the Beethoven 
mouse mutant) alters the calcium permeability of the MET channel, as well as the response to 
the aminoglycoside (AG) dihydrostreptomycin (DHS) which is known to bind to the inside of the 
channel pore (Corns et al., 2016).  
One of the major hurdles in concluding the roles of TMC1 and TMC2 in the MET channel 
permeation pathway was that for a long time attempts to show that either of these proteins 
could form an ion-conducting pore in a lipid bilayer failed, bar one report (Chatziegeorgiou et 
al., 2013). Recently however evidence for TMC1 and TMC2 as the pore-forming subunits of the 
MET channel has been mounting. In 2018, Pan et al. used cysteine mutagenesis carried by 
AAV2/1 viral vectors expressing 18 variants of mouse TMC1 and showed that several of these 
sites caused reduction or total abolishment of transduction currents. They further found that 
for 5 of these, treatment with MTSET (which irreversibly binds to cysteine residues) caused 
further non-recoverable reduction of the transduction current, indicating that these sites likely 
line the pore of the channel. Homology modelling of TMC1 with the related TMEM16 proteins 
revealed a wide anionic cavity near the surface of the protein, indicating a potential cation 
permeation pathway (Ballesteros et al., 2018). Intriguingly, these two studies also indicate that 
TMC1 likely assembles as a dimer. Soon after, the same group that created the viral vectors for 
TMC1 showed that gene therapy in mice with deficiencies in Tmc1 restored hearing and balance 
(Nist-Lund, 2019). And finally, a recent study managed to express isolated TMC1 from the green 
sea turtle and TMC2 from the budgerigar in insect cells and showed that these could elicit ion 
channel activity (Jia et al., 2020).  
 
1.2.5 Understanding the tonotopic gradient in OHC MET channel kinetics 
There are many gradients in the cochlea which influence mechanotransduction. In fact, the MET 
channel itself varies in several aspects of its kinetics, following the tonotopic axis. Understanding 
the mechanisms of this gradient is not entirely straightforward and requires some picking apart 
of the evidence presented by the scientific community over the last few years.  
The first evidence for a tonotopic gradient in mechanotransduction of OHCs was the observation 
that twice as much calcium entered basal cells during depolarisation than apical cells (Ricci et 
al., 2000). Then, a gradient was found in the rate of adaptation of the MET channel (Ricci, 2002), 
and it was found to exhibit a gradient in macroscopic, whole-cell conductance, with basal cells 
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eliciting larger currents than apical cells (Ricci et al., 2003; Beurg et al., 2006; Lelli et al., 2009; 
Desmonds, 2015). Furthermore, a visible gradient in the passage of large fluorescently tagged 
molecules has often been reported, for example FM1-43 (Gale et al., 2001), GTTR (Dai et al., 
2005), D-JNKi1 (Desmonds, 2015), and dextran-TR (Ballesteros et al., 2018), with basal cells 
always showing considerably strongly labelling than apical cells. The reason for these 
observations could easily be interpreted as basal cells having more channels than apical cells. 
But there are many reports that measures of single-channel activity by breaking tip links with 
BAPTA show that the gradient in channel conductance persists at the level of individual channels 
(Ricci et al., 2003; Beurg et al., 2006; Kim and Fettiplace, 2014; Beurg et al., 2015; Beurg et al., 
2018).  
The question remains of what is setting up these differences. As mentioned, during development 
there is a gradual change in the expression pattern of TMC1 and TMC2, with TMC2 initially 
dominating the entire coil, and expression of TMC1 starting from the base and moving up to the 
apex so the mature MET channel only contains TMC1 (figure 1-7) (Kawashima et al., 2011; 
Kurima et al, 2015). The function of TMC2 in the cochlea is unclear and has been suggested to 
be an evolutionary remnant (Corns et al., 2017), as its expression persists in vestibular cells 
which are similar to immature apical cells of the cochlea and likely to be evolutionarily related.  
Pan et al. (2013) proposed that the variable dynamics of the MET channel in neonatal OHCs may 
depend on the expression profiles of TMC1 and TMC2 in each cell due to differences in 
conductance between the two isoforms. But subsequent evidence has emerged than TMC1 itself 
has a gradient in single-channel conductance, and TMC2 a similar but much smaller gradient 
(Kim et al., 2013; Beurg et al., 2018). Beurg et al. (2018) go so far as to suggest the existence of 
several variants of TMC1 each with distinctive “levels” of conductances, apparently in multiples 
of approximately 50 pS. They further propose evidence for multiple TMC1 pores at each MET 
channel complex (~8 in the apex and ~20 in the base), beyond the TMC1 dimers that have also 
been recently suggested (Pan et al., 2018, Ballesteros et al., 2018). The molecular correlates of 
this variation in conductance is uncertain, as are the details of how such multiple TMCs would 
be cooperatively gated by the tip link (Sul and Iwasa, 2010). There are also suggestions of 
multiple phosphorylation sites on TMC1 (Pan et al., 2018), implicating the possibility of 
posttranslational modifications in channel configuration (Corey et al., 2019).  
Another interesting avenue is a variation in tip link stiffness and rotation recently reported by 
Tobin et al. (2019), which could impact gating of the MET channel. However, a difference in 
tension should cause a difference in resting open probability which is not seen (Tobin et al., 
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2019). If there were an active gating mechanism in between the tip link and the channel pore 
this could potentially compensate for differences in tension until the channel is opened. Thus, 
differences in channel tensioning could be involved in the conductance levels seen by Beurg et 
al. (2018) through distortion of the channel pore. Tobin et al. found no gradient in the tensioning 
of IHC tip links, which matches the lack of a gradient in IHC single-channel conductance  
(Pan et al., 2013; Pan et al., 2018; Beurg et al., 2018; Corey et al., 2019).  
The current models by which MET channel conductance modulation is achieved are by no means 
complete. Because this thesis addresses questions of differences in channel kinetics between 
the apex and base, I will further discuss the models of graded transduction and how my 










1.3 Hearing loss and ototoxicity 
Due to their incredible complexity, the sensory hair cells of the inner ear can easily be damaged 
by excessive exposure to noise, through genetic mutation, or by a variety of ototoxic compounds 
that make their way into the endolymph of the ear. As mammals we only get one set of sensory 
hair cells in our lifetimes. If they die, this causes permanent hearing loss. As such it is important 
to protect them and doing so requires an understanding of how they function and how they can 
be damaged.  
 
1.3.1 General causes of hearing loss 
Hearing loss and deafness are complex disorders that can manifest from a wide range of issues 
within the auditory system. In the brain, hearing loss is usually due to a lesion in the central 
auditory pathway. Types of central hearing loss includes aphasia, pure word deafness, auditory 
agnosia, and central presbycusis in which speech discrimination in the elderly is worse than 
expected given their hearing thresholds (Willcox and Artz, 2007). The existence of this latter 
condition is debated (Humes et al., 2012). In these conditions, the peripheral auditory apparatus 
is behaving as normal, but the brain is not processing the signal correctly if at all. The more 
common cause of hearing loss is peripheral, of which there are two types: conductive and 
sensorineural. In conductive hearing loss the outer and middle ear do not transmit sound to the 
inner ear properly, due to for example: damage to the ear drum, fixation of the ossicles, or wax 
impaction (Cunningham and Tucci, 2017). Fortunately, these conditions can usually be 
successfully treated to restore hearing.  
Sensorineural is the more alarming type of peripheral hearing loss. Sensorineural hearing loss 
occurs when there is dysfunction within the cochlea. It can arise due to problems with the 
maintenance of the endocochlear potential by the stria vascularis (Wangemann, 2006), or with 
damage to the spiral ganglion neurons in the auditory nerve (Starr and Rance, 2015). But it is 
usually due to loss of sensory hair cells (Cunningham and Tucci, 2017). Unfortunately, mammals 
cannot regenerate hair cells, so this type of hearing loss is often permanent. Furthermore, loss 
of hair cells leads to degeneration of the auditory nerve over a period of several months, 
rendering the use of cochlear implants ineffective if not implemented quickly (Cunningham and 




One common cause of hair cell loss is exposure to excessively loud noise, especially for 
prolonged periods of time—musicians are at high risk of this, as are people who work in 
construction and airports. Moreover, concerts, movie theatres, loud fitness classes, shooting, 
and listening to music through headphones can all be sources of damage. A temporary threshold 
shift refers to short term hearing loss after noise exposure and can be reversed—though it may 
leave a mark on hair cell synapses (Kujawa and Liberman, 2009)—but repeated exposure can 
make it permanent (Cunningham and Tucci, 2017).  
Age-related hearing loss in the elderly population is widespread and is generally due to the 
accumulation of noise exposure and ototoxic factors within the ear, but it can also be hereditary. 
Age-related hearing loss commonly begins at higher frequencies and moves down, making 
speech progressively difficult to understand (Allen and Eddins, 2010; Cunningham and Tucci, 
2017). Hereditary genetic mutations that result in hearing loss affect approximately 1 in 1000 
new-borns, while adult-onset hearing loss affects between 25 and 55% of the population 
(Cunningham and Tucci, 2017). Over 100 genes have been identified that result, when mutated, 
in nonsyndromic hearing loss (i.e. they do not produce any other disorders of the body), with an 
additional 500 genes implicated in syndromes that include hearing loss (Cunningham and Tucci, 
2017). 
 
1.3.2 Aminoglycoside-induced ototoxicity 
Another cause of hearing loss is unfortunately by medically prescribed ototoxic drugs. These 
drugs include the aminoglycoside antibiotics (AGs), and the anti-cancer drug cisplatin. Among 
the most commonly used AGs are gentamicin, kanamycin, tobramycin, neomycin (only used 
topically), and amikacin. In the West, AGs are confined to use in life-saving situations, but in 
developing countries are more commonplace due to their broad spectrum of activity, stability, 
and rapid bactericidal activity (Krause et al., 2016; O’Sullivan et al., 2017). AGs are prescribed in 
the treatment of dangerous gram-negative pathogens such as sepsis, neonatal infections, 
tuberculosis (Krause et al., 2016), endocarditis (O’Sullivan et al., 2017) and are often given 
long-term to cystic fibrosis patients to prevent repeated infections (Krause et al., 2016; 
Cunningham and Tucci, 2017). Unfortunately, AGs cause some degree of irreversible hearing 
loss in 20-30% of patients (Duggal and Sarker, 2007; Schacht et al., 2012) as well as generally 
reversible damage to the kidneys (nephrotoxicity) (Lopez-Novoa et al., 2011).  
It is difficult to relate the dosage of AGs given to patients and the resulting the concentration in 
the endolymph of the cochlea that will cause hair cell death. Furthermore, patients have varying 
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susceptibilities to AG ototoxicity. The closest estimate for the concentration of AG in the 
endolymph that will cause ototoxicity is approximately 1 M (Tran Ba Huy et al., 1981). AGs 
permeate into hair cells primarily via the MET channel due to their polycationic charges 
(Marcotti et al., 2005; van Netten and Kros, 2007; Alharazneh et al., 2011; Corns et al., 2016; 
O’Sullivan et al., 2017). Once inside the cell, build-up of AGs causes ototoxicity and cell death 
mainly through disruption of protein synthesis by binding to the 30s ribosomal subunit (Davies 
and Davis, 1968; Cabañas et al., 1978; Tanaka, 1983) and through inhibition of mitochondrial 
respiration (O’Reilly, 2019).  
In the lab, we use excised mouse cochleae to understand the mechanisms of ototoxicity. 
Organotypic cochlear cultures can be incubated with AGs to look at their deleterious effects 
(figure 1-8) (Russell and Richardson, 1987; Kotecha and Richardson, 1994; Alharazneh et al., 
2011; Kenyon et al., 2017; O’Reilly et al. 2019; Kitcher et al., 2019; Kros and Steyger, 2019; 
Osgood, 2020). Members of the AG family vary in severity of ototoxicity: cultures incubated with 
the same concentration of different AGs will have varying levels of hair cell death, with 
gentamicin being the most toxic (Kotecha and Richardson, 1994). The mechanism for this has 
thus far been unknown. It has been assumed that these differences were related to intracellular 
pathways for activating apoptosis. Patients with AG-induced ototoxicity tend to predominantly 
lose high-frequency hearing (Al-Malky et al., 2011, Garinis et al., 2017). Interestingly, ex vivo 
organotypic cochlear cultures that are incubated with AGs also display a gradient in OHC toxicity 
with basal hair cells dying at lower concentrations of drug than apical cells (Kotecha and 
Richardson, 1994, Wu et al., 2001, Alharazneh et al., 2011; O’Reilly, 2019; Kitcher, 2019) 
following the tonotopic gradient in fluorescent labelling. The reason for this has also thus far 
been unclear and is generally thought to be related to differences in channel number, size, and 




1.3.3 Preventing ototoxicity by targeting the MET channel 
The large size of the MET channel pore leaves the hair cells vulnerable to molecules that would 
not normally permeate into other cells. Some compounds have been found to provide 
protection against gentamicin in culture, though these mainly act through decreasing the 
formation of reactive oxygen species and generally do not confer protection in vivo (Kitcher, 
2019). Perhaps a better strategy towards otoprotection is to prevent the entry of gentamicin 
into hair cells. A recent focus of the Richardson and Kros labs has been to find otoprotectants 
that reversibly block the MET channel and stop AGs from entering the cell through this route 
(Kirkwood et al., 2017; Kenyon et al., 2017; O’Reilly et al. 2019; Kitcher et al., 2019). Ideally, a  
co-administered compound would temporarily and reversibly block the MET channel with no 
other deleterious effects, preventing AG entry into the cell and thus protecting the hair cells 
from death.  
Through a screen of over 10,000 compounds for hair cell protection again neomycin in zebrafish 
(5,000 of which I screened myself during an undergraduate summer project), several 
compounds have been identified with otoprotective potential that are currently undergoing 
further testing in vitro and in vivo. Some of the compounds that our lab has studied have recently 
been published, including a smaller screen of ion channel modulators (Kenyon et al., 2017), and 
a paper on two promising otoprotective compounds, d-turbocurarine and berbamine (Kirkwood 
et al., 2017). Unfortunately, berbamine was found to be highly toxic at higher concentrations 
(>30 µM), so its value as an otoprotectant in vivo may be questionable. Nevertheless, these 
compounds are a promising proof-of-principle for otoprotection by competing for entry into the 
OHCs at the level of the MET channel. Further promising compounds include a derivative of 
carvedilol (O’Reilly et al. 2019) and the novel compound ORC-13661 (Kitcher et al., 2019). All the 
compounds here mentioned have been found to interact with the MET channel, producing 
reversible block of inward MET channel currents, and thus presumably competing for entry with 
ototoxic drugs (Kirkwood et al., 2017; O’Reilly et al., 2019; Kitcher et al., 2019). 
Finding otoprotectants through this pipeline has thus far produced some viable candidates, but 
the process is slow and challenging. Furthermore, there are still no FDA-approved 
otoprotectants, so the search is still on. A deeper understanding of the way in which AGs 
permeate through the channel could help guide and refine the search, and it could eventually 




1.3.4 Modelling the MET channel as a tool to aid in the search for 
otoprotectants 
As drugs permeate through the channel, they leave a signature mark: a reduction in current as 
they transiently bind to the inside of the pore. This block is usually voltage- and concentration-
dependent so that extracellularly applied drugs block the channel at hyperpolarised membrane 
potentials when the channel is opened by excitatory deflections of the hair bundle.  If the drugs 
are permeant, then block of the channel at most negative potentials is relieved, indicating that 
the driving force on the molecules overpowers their binding to the channel pore and forces them 
into the cell. By modelling data from whole-cell patch-clamp electrophysiology, we can measure 
this signature and determine the permeation properties of the drugs.  
We currently employ a two-barrier one-binding site model that describes this entry (figure 1-9) 
(Marcotti et al., 2005; van Netten and Kros, 2007; Corns et al., 2016; Kirkwood et al., 2017) based 
on a model produced by Woodhull in 1973 to describe H+ permeation through a Na+ channel in 
frog nerve cells and more generally adapted for ion channel permeation in Hille, 2001. According 
to this model, as drugs pass through the channel, they encounter a first energy barrier at the 
entrance to the channel pore. Upon overcoming this barrier, they bind to an area of negative 
charge on the inside of the channel pore and block inward current to the cell. Finally, they 
overcome a second barrier at the exit of the pore and permeate into the cell. The profile of this 
interaction between a drug and the MET channel can be obtained by fitting the two-barrier  
one-binding site model to a full complement of fractional block curves measured across a range 
of voltages.  
The Hill coefficient (nH) describes the degree of cooperativity between the blocker and the pore 
(Hille, 2001), and can be obtained by fitting dose response curves of drug block with the  
Hill equation at individual voltages. A neutral Hill coefficient of 1 generally indicates an 
interaction between a single drug molecule and a single binding site. A Hill coefficient above 1 
may indicate cooperativity in which binding of one drug molecule increases the probability of a 
second or more molecule(s) binding to other sites within the permeation pathway, whereas a 
Hill coefficient below one may point to negative cooperativity, where binding of one molecule 
reduces the probability of a another binding to other sites. Examples of each of these types of 
interactions have been demonstrated between various drugs and the MET channel (Gale et al., 
2001; Marcotti et al., 2005; Desmonds, 2015; Corns et al., 2016). 
The full permeation characterisation of only one AG, dihydrostreptomycin (DHS), has thus far 
been published (Marcotti et al., 2005). The half-blocking concentration (KD) of DHS at a 
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membrane voltage of -84 mV was found to be 7 µM, and the block was only seen on inward 
currents (Marcotti et al., 2005). Furthermore, single excitatory force step stimuli at a fixed 
membrane voltage of -84 mV showed a large inward current followed by rapid decline, and a 
slow closure upon stepping to the inhibitory direction (Marcotti et al., 2005). The entry rate for 
DHS into OHCs was calculated at 9000 molecules per second per OHC at therapeutic 
concentrations (Marcotti et al., 2005). The Hill coefficient for DHS was found to be 
approximately 1 across the voltages in which it produced block, indicating a single binding site 
for DHS within the channel pore.  
To date only preliminary data have been acquired with regards to the channel-blocking effects 
of the clinically relevant AG gentamicin and its fluorescent-tagged companion, gentamicin 
Texas-red (GTTR), or any of the other clinically used ototoxic AGs.  Little study has been done on 
the differences in drug permeation between apical and basal OHCs. It is also unknown what the 
effects of maturation would be on AG permeation at the level of the channel, and how these 
might differ from the neonate commonly used to model ototoxicity. Furthermore, the molecular 
correlates inside the TMC1 permeation pathway for the sites of interaction described by our 





1.4 Thesis aims 
The overarching goal of this thesis is to better understand the mechanism by which ototoxic 
drugs permeate through the very channel that makes the hair cells so special: the MET channel. 
The permeation of these drugs is fascinating both for understanding the physiology of 
mechanotransduction, and for understanding what makes these cells vulnerable and how we 
can help protect them in the fight against hearing loss.  
 
Specifically, I aim to: 
• Investigate the permeation properties of several AGs, how these differ from each other 
and how these are related to their degrees of toxicity in hair cells. 
• Investigate the permeation properties of GTTR, how these may differ from native 
gentamicin and what this could mean for its use as an indicator of gentamicin 
permeation. 
• Investigate tonotopic variation in the permeation of the MET channel by AGs. 
• Investigate how maturation and genetic mutation might affect permeation through the 
MET channel. 
• Identify a potential alternative route of entry for ototoxic drugs into hair cells. 
• Provide insight into the permeation pathway of the MET channel, and how comparative 























2.1 Acute and cultured tissue preparation 
2.1.1 Use of acute and cultured cochleae 
Acute or cultured preparations were used depending on the experiment. Acute preparations are 
generally favoured for electrophysiology as they are simpler in preparation and do not require 
aseptic technique. There is also a range of ages from which the cochleae can be dissected, 
offering more days of potential testing and the option to examine changes in the 
electrophysiology of hair cells over early postnatal days. Cultured preparations are useful for 
drug screening as they can be incubated with compounds to examine long-term cell toxicity. 
Cultures were used in the portions of this thesis directly comparable to ototoxicity experiments 
to keep conditions consistent with those data.  
MET currents are typically more stable in cultures, except in Tecta/Tectb-/- mutants which have 
exceptionally large and consistent MET currents even in acute preparations. I believe this is 
because the process of dissection (particularly the removal of the tectorial membrane) may 
temporarily damage the tip links, rendering the MET currents recorded from acute preparations 
generally rarer and smaller. This is especially evident in basal OHCs in which recording from 
acute preparations is unreliable, so cultures were used for making apical-basal comparisons as 
this gives time for the tip links to repair (Zhao et al. 1996, Indzhykulian et al., 2013). 
 
2.1.2 Animal husbandry and preparation type 
Animals were bred in the University of Sussex Life Science department facility following UK 
Home Office regulations, and mice of either sex were used. Swiss CD-1 mice were originally 
obtained from Charles River, and were used for making the cochlear cultures in chapters 3 and 
4, parts of chapter 5, and chapter 7. Asic1b-/- mice in chapter 6 were obtained from Professor 
Shinya Ugawa (Nagoya, Japan) and the cochleae were prepared acutely. Tecta/Tectb-/- mice in 
chapter 5 were made in house by Professor Guy Richardson and the cochleae were prepared 







2.2.3 Acute cochlear preparation 
Acutely isolated cochleae were prepared from postnatal day (P) 2-10 mouse pups depending on 
the experiment and the strain of mice. The mice were killed by cervical dislocation in accordance 
with UK Home Office regulations (Schedule 1), and death was confirmed by removal of the head. 
The heads were bisected, brains removed, and the inner ears excised and transferred whole to 
a clean dish of ice-cold extracellular medium (made as described in section 2.2.2). From this 
point the inner ears were kept on ice until just before the start of a recording session, for a 
maximum of 2 h. When the experiments were ready to begin, the cochleae were dissected by 
removal of the cartilaginous or bony (depending on age) shell, the modiolus, and stria vascularis, 
leaving the organ of Corti. The basal turns of the cochleae were cut off to flatten the 
preparations. The apical turns were transferred with a spoon to the recording chamber and 
clamped underneath a nylon grid pulled taught over an aluminium ring in order to expose the 
OHCs of the mid-apex for recording (figure 2-1, panel A). Finally, the tectorial membranes were 
removed with fine forceps to expose the stereocilia.  
 
2.1.4 Cultured cochlear preparation 
Organotypic cochlear cultures were prepared from P2 CD-1 mice (Russell and Richardson, 1987). 
As for acute preparations, the mice were killed by cervical dislocation, and the heads were 
removed. The heads were surface sterilised by three one-minute washes in 80% ethanol, then 
bisected and transferred to dishes containing 10 mM HEPES-buffered Hanks’ Balanced Salt 
Solution (ThermoFisher 14025050). The cochleae were dissected as for acute preparations but 
using aseptic technique under a laminar flow hood and leaving the basal turn and tectorial 
membrane intact. The organs of Corti were plated onto collagen-coated (Corning 354236) 
coverslips (ThermoFisher 10256354) and fed with cochlear culture medium (93% DMEM-F12 
(Sigma-Aldrich; D8062), 7% fetal bovine serum (Thermo Scientific; HyClone SV30180-03) and 
2μg.ml-1 ampicillin). The cultures were wax-sealed in glass Maximow dishes and incubated at 
37C, 5% CO2 for 24-48 hours, allowing time for the tissue to adhere to the collagen and grow 







2.2.1 Experimental equipment 
I spent the first five months of this PhD building my electrophysiology setup. This gave me a 
thorough understanding of the wiring and operation of the system, and the opportunity to tailor 
it specifically to the experiments ahead. A large part of the building process involved 3D printing 
of custom components (for example, the chamber in figure 2-1). I mostly used an Ultimaker 2+ 
3D printer and designed objects using Google Sketchup.  
The cells were viewed on an upright microscope (Zeiss, Germany) using Nomarski Differential 
Interference Contrast optics (63X water immersion objective (Leica, UK), plus 15X eyepieces), 
and monitored with a QICAM Fast 1394 CCD camera (QImaging, BC, Canada) through Manager 
(Edelstein et al., 2014). 
Currents were recorded and amplified by an Axopatch 200b (Axon Instruments, Union City, CA), 
filtered at 10kHz (except where otherwise noted) using an 8-pole Bessel filter, digitised with a 
Cambridge Electronic Devices (CED) Power 1401 and sampled at 20kHz (except where otherwise 
noted) using Signal v6.03 (CED, Cambridge, UK). The CED Power 1401 also sends a signal 
generated by Signal to a piezo driver, which powers the fluid jet stimulator. The setup is shown 
in figure 2-2, panel A. 
The ground signal from the bath was passed through an external calibrator so that cells could 
be clamped at -80 mV constantly even when not running a protocol from the computer, thus 






2.2.2 Solutions and patch pipettes 
Preparations, either acute or cultured, were placed in the microscope chamber and continually 
perfused with extracellular solution. This contained (in mM):  135 NaCl, 5.8 KCl, 1.3 CaCl2,  
0.9 MgCl2, 0.7 NaH2PO4, 5.6 D-glucose, 10 HEPES-NaOH, 2 sodium pyruvate (pH adjusted to 7.5 
with 1M NaOH, osmolality ~305 mOsmol kg-1). This solution also contained amino acids and 
vitamins for Eagle’s minimum essential medium, without L-glutamine (Invitrogen).  
Additionally, OHCs were superfused with test drugs by a 4-channel gravity-driven manifold 
leading into a 200 m nozzle at a ~100 angle to the hair bundles to minimise effect on the 
stereocilia. This allowed each cell to be tested at up to 3 concentrations of drug, plus control. 
The control superfusion solution contained (in mM): 145 NaCl, 5.8 KCl, 1.3 CaCl2, 0.9 MgCl2, 0.7 
NaH2PO4, 5.6 D-glucose, 10 HEPES-NaOH, 2 sodium pyruvate (pH adjusted to 7.48 with 1M 
NaOH, osmolality ~310 mOsmol kg-1) and into this were diluted stock concentrations of test 
drugs. This solution was modified where indicated in chapters 5, 6, and 7. AGs were purchased 
from Sigma-Aldrich and stored at 4C. Gentamicin-Texas red (GTTR) was obtained from 
Professor Peter Steyger (Creighton University).  
Patch pipettes were pulled from soda glass capillaries (Harvard Apparatus, Edenbridge, UK) using 
a Narishige PC-10 (London, UK) puller and the shank was coated with surf wax (Mr Zogs SexWax, 
Carpinteria, CA, USA) to reduce surface capacitance. Patch pipettes had a resistance of about 
2.6 M and were filled with an intracellular solution containing (in mM): 137 CsCl, 2.5 MgCl2,  
1 EGTA-CsOH, 2.5 Na2ATP, 10 sodium phosphocreatine, 5 HEPES-CsOH (pH adjusted to 7.3 with 
CsOH, osmolality ~295 mOsmol kg-1). Caesium-based solution was used to block voltage-gated 
potassium channels in the basolateral membrane of the OHCs and thus reduce noise and  
series-resistance errors in MET current recordings. The extracellular and intracellular solutions 
were estimated to produce a liquid-junction potential of approximately -4 mV which was 
included in all mentions of cell voltage in this thesis.  








2.2.3 Whole cell recording of MET currents 
Whole-cell patch clamp recordings were made from third-row OHCs in either the apical (9-12 
kHz region) or basal (30-36kHz region) turn of the cochlea. All recordings were performed at 
room temperature (21-23C). The supporting cells directly adjacent to the OHCs were removed 
by suction through a glass micropipette with a 10-12m tip filled with extracellular solution, 
exposing the basolateral membrane. If recording from the basal end of a culture and the 
tectorial membrane was too close to the hair bundles, it was removed by suction with a  
15-20 m pipette.  
Patch pipettes was manoeuvred close to the cell with positive pressure so that a small dimple in 
the cell membrane could be seen. Once positioned, positive pressure was removed, and gentle 
negative pressure applied until a seal of at least 1 GOhm formed with the cell membrane. At this 
point, the calibrator was set to hold the cell at -80 mV. Sharp negative pressure was applied to 
break the cell membrane and gain access to the inside of the cell. Whole-cell capacitance and 
resistance were compensated for, and series resistance compensation was applied up to 80%. 
Hair bundles were mechanically stimulated using a fluid jet driven by a piezoelectric disc  
(Kros et al., 1992) to produce MET channel currents. Stimuli were calibrated at the start and 
throughout experiments to produce saturating excitation of the MET channel, thereby 
minimising adaptation. Gentle negative pressure was kept constant in the fluid jet to allow 
suction of superfused drugs and avoid mixing of solutions. The recording configuration is 











2.3 Recording protocols and primary data analysis 
The procedure described here applies to chapters 3, 4, and parts of chapter 5. Specific recording 
and analysis methods for the remaining experiments are described in those chapters.   
The main recording protocol offered a characterisation of the effects of voltage on drug block 
during a standard sine wave. Sine waves were preferred to ensure saturating stimulation of the 
MET channel, which is evident as a flattening of the current in the range of maximal bundle 
deflection (figure 2-4). The protocol consisted of a 4-cycle sinewave stimulation at 45 Hz, 
combined with 14 voltage steps in 20 mV increments ranging from -164 mV to +96 mV (corrected 
for liquid-junction potential) (figure 2-4). Recordings were repeated 2-3 times per condition.  
At the end of each experiment, recordings were batch exported from Signal native format .cfs 
to .txt using a script graciously provided by a CED employee. Primary off-line analysis of the data 
was done in OriginPro 2019 (OriginLab, Northampton, MA), using custom-written scripts in 
LabTalk for batch processing. Current-voltage (IV) curves were calculated by determining 
maximal MET current size at each voltage and subtracting the current during inhibitory 
stimulation from the current during excitatory stimulation. The maximal current was averaged 
for each phase of the sine wave, omitting the first. The IV curves for multiple repetitions in the 
same cell were averaged. Fractional block curves were obtained by dividing the averaged IV 
curve during superfusion of test drug by the averaged IV curve during superfusion of control 
solution (figure 2-5). The point at -4 mV is omitted due to large errors incurred by dividing small 
values by one another. 
The second main recording protocol was aimed at determining the temporal kinetics of the 
channel. As previously found, AGs act as open-channel blockers of the MET channel (Marcotti et 
al., 2005). Upon deflection of the hair bundle, a large inward current first appears that then 
declines to a steady state. The time course of this decay in current is related to the speed with 
which the molecules overcome the first energy barrier at the entrance of the channel, as 
described in section 2.4.1. Time constants were calculated by fitting an exponential decay 
function to the decay in current at the start of stimulation during excitatory square force steps 
of the hair bundle:  
𝐼 =  𝐼0  +  𝐴 𝑒
−(𝑡 − 𝑡0)/𝜏, 
(eq. 1) 




Two protocols were used as shown in figure 2-6. The basic protocol consisted of holding the cell 
at the voltage of maximal block for the drug and stimulating with an excitatory force step (figure 
2-6, panel A). This protocol worked well for gentamicin and GTTR which had a large, relatively 
slow current decay upon channel opening.  
However, because the decay was much faster for kanamycin and amikacin an alternative 
protocol was used as described in Marcotti et al., 2005. This protocol consisted of a depolarising 
voltage step to +96 mV which releases the block, followed immediately by a hyperpolarising step 
to -124 mV for kanamycin, or -144 mV for amikacin, all during excitatory stimulation of the 
bundle (figure 2-6, panel B). This led to block that was purely brought on by voltage of maximal 
block, and therefore not dependent on the kinetics of the fluid jet. For this protocol, the data 
were filtered at 20 kHz and sampled at 100 kHz. Capacitive transients at the start and end of the 
voltage steps as well as linear leak and voltage-dependent membrane currents were removed 
by subtracting recordings from identical voltage steps in the absence of fluid-jet stimulation. 
Because they were so fast, time constants for amikacin and kanamycin especially were 












2.4 Channel modelling 
2.4.1 Two-barrier one binding-site model of permeation of the MET 
channel 
To model permeation of drugs through the MET channel, we fit a two-barrier one-binding site 
model to the fractional block and time constant data and extract parameters that describe the 
biokinetics of the interaction between molecules and the channel pore (Marcotti et al., 2005; 
van Netten and Kros, 2007). Calculating these parameters requires a complete dataset with a 
compound tested at multiple concentrations spanning its entire dose response range from no 
block to full block.  
In brief, the model can be described as such:  






 + 𝐵𝑖 
(eq. 2) 
where C is the channel, B is the blocking agent (Bo, outside and Bi, inside). In this model, k1 and 
k2 are the binding constants, and k-1 and k-2 are the dissociation constants over the first and 
second energy barriers. This model represents a system in which the blocker overcomes the first 
energy barrier to bind to the inside of the open channel, transiently binds to the inside of the 
channel pore, then overcomes a second barrier to permeate into the cell.  
Dose response curves were generated at each of the 7 most negative voltage steps of the 
fractional block curves and were fitted with the Hill equation to calculate the half-blocking 
concentration (KD) and Hill coefficient (nH): 
𝐼𝑑𝑟𝑢𝑔
𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙










where Icontrol is the control current and D is the concentration of the drug in the extracellular 
solution.  
Fractional block curves were fitted with the two-barrier one-binding site model: 
𝐼𝑑𝑟𝑢𝑔
𝐼𝑐𝑜𝑛𝑡𝑟𝑜𝑙
= (1 + (𝑒 (𝐸𝑏 +















where Eb is the free energy of the binding site in the channel pore (expressed in terms of  
kT: 4.1 x 10-21 J), δb is the fractional position, from the outside, of the binding site across the 
electrical field of the membrane, Vm is the membrane potential in mV, 26 is kT/e (the unitary 
charge) in mV, z is effective valence of the drug D; and ΔE is the difference between the two free 
energy barriers: the free energy of the barrier E2 on the intracellular side minute the free energy 
of the barrier E1 on the extracellular side (again in terms of kT). 
The inverse of the time constants as a function of drug concentration were fitted with a linear 
regression line in order to calculate the slope, which in this model equals k1:  
𝜏−1 = 𝑘1[𝐵𝑜]
𝑛𝐻 + 𝑘−1 + 𝑘2 
(eq. 5) 
Using these parameters, the values that describe the energy profiles and entry rates of drug 
permeation were calculated as follows: 











𝐸𝑏+𝛿𝑏(𝑉/𝑉𝑠)(1 + 𝑒−ΔE−(𝑉/𝑉𝑠)) 
(eq. 8) 





























where V0 is the potential of maximum block, 𝑧 is the valence (apparent charge) of the blocker, 
𝑞𝑒 is the elementary unit of charge (1.6 x 10
-21 C), KD is the voltage-dependent half-blocking 
concentration, E1 and E2 are the first and second energy barriers, k-1, k2, and k-2 are the forward 
and reverse rate constants over the two energy barriers, and NE is the entry rate at a given 
concentration, D (in M). 
 
2.4.2 Model automation in Python 3.0 
I automated the process of modelling the drug permeation of the MET channel in Python 3.0 
with the help of Mr. Joshua Porter. This reduced human error when performing calculations 
across multiple datasets and allowed me flexibility in adjusting fitting parameters and to process 
datasets consistently and rapidly. The automated model starts by taking file inputs for mean 
fractional block and for raw time constant data, using the pandas package to load and structure 
the data by index. At the start is the option to specify initiation and fixing of values for certain 
parameters of the global fitting later: for example, binding energy and Hill coefficient. This is 
crucial when swapping between native AGs and GTTR, as they have vastly different fitting 
parameters. There is also the option to set the fixed parameters to calculate the entry rate 
through channel in the final stages, such as number of channels per cell, concentration of drug, 
resting open probability, and temperature.  
Curve fitting of the data is done using the scipy function curve_fit (Virtanen et al., 2020). This 
function performs a least-squares minimisation using the Levenberg-Marquardt algorithm. It 
takes initiation values and bounds for each fitting parameter. When first running a dataset, these 
values are estimated from the literature or from previous datasets and then manually adjusted 
according to the results to produce the best fit. For example, the binding energy for gentamicin 
was originally estimated to be about -10 kT based off previous results for DHS (Marcotti et al., 
2005). This proved very similar to the final result, and further adjustments did not affect the fit. 
By contrast, the initiation value for the binding energy of kanamycin was adjusted to -5 kT to 
produce the best fit. Similarly, the parameter bounds are set to encompass the potential fit 
values by a wide margin. 
The first calculation is fitting the dose response curves (eq. 3). The script loops through each 
voltage in the index of the dataset and fits the Hill equation at each voltage, appending the 
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values for the half-blocking concentration (KD) and the Hill coefficient (nH) each to a list. The 
script then does a global fit of the two barrier-one binding site model to the entire fractional 
block dataset with two dependent variables: voltage and concentration (eq. 4). The next 
calculation is fitting a linear regression through the time constant data (eq. 5). The slope from 
this fit (k1) is returned, as this corresponds to the rate over the first energy barrier later in the 
modelling process.  
The final stage is generating the energy profile and entry rates using the fitting results. First, 
constants are defined such as the Boltzmann constant and the proportionality constant for the 
first order rate constant. Then, the MET channel permeation model is given 13 parameters (the 
values of which are either specified constants or from the fits) and returns the following: entry 
rate, potential of maximum block (V0), first and second energy barriers (E1 and E2), both reverse 
constants (k-1 and k-2), and the time constant over the second energy barrier (k2) (eq. 6-15). These 
values are used to plot the energy profiles and entry rate graphs.  
Sample scripts and datasets are available in GitHub repository 
(https://github.com/Xenothy/METchannelpermeationVM). Figures were made using OriginPro 
2019 or Matplotlib 3.2.1 and edited in Adobe Photoshop CC 2019. All errors quoted and figure 
error bars are 95% confidence intervals. The confidence intervals are reported in the text and 




















Comparing the Permeation Properties 
of Three Clinically Relevant 




















Gentamicin, kanamycin and amikacin (figure 3-1) are used for a wide range of antibacterial 
treatments, and all three of these AGs can cause hearing loss, tinnitus, and/or vestibular 
disfunction. AGs do not take up very well in the GI tract and are generally administered 
systemically or topically (Kushner et al., 2016). It is difficult to determine the dosage of AGs that 
will lead to hearing loss (Kushner et al., 2016), probably due to variation in how effectively they 
will enter the endolymphatic space of the inner ear (Li and Steyger, 2011). It is thought that 
administering AGs in larger doses less frequently may reduce incidence ototoxicity, and this 
dosing does not detrimentally impact treatment effectivity (Kushner et al., 2016; Krause et al., 
2016).  
These three members of the AG family also have vastly different levels of toxicity to hair cells in 
vitro when given at the same concentration (figure 3-10), as has been previously suggested 
(Kotecha and Richardson, 1994). The reason for these differences is at present unclear. AGs 
clearly enter the hair cell primarily through the MET channel as any manipulation that reduces 
or abolishes mechanotransduction prevents AG ototoxicity in vitro (Gale et al., 2001; Marcotti 
et al., 2005; Owens et al., 2009; Kawashima et al., 2011; Alharezneh et al. 2011; Kenyon et al., 
2017; O’Reilly et al., 2019; Kitcher et al., 2019). Entry via endocytosis at the cell membrane is 
also reported but is thought not to overwhelm the cell as entry is slower than via the MET 
channels and the drugs are already within compartments for degradation (Hailey et al., 2017). 
Furthermore, it is widely reported that basal OHCs are more sensitive to AG ototoxicity than 
apical cells even in culture. I have therefore compared the permeation properties of gentamicin, 
kanamycin, and amikacin in both apical and basal OHCs to determine whether differences in 
toxicity may be related to permeation rate through the MET channel.  
Gentamicin is given in clinic as a mix of several isoforms and there is indication that some 
isoforms are more ototoxic than others (O’Sullivan et al., 2020). The gentamicin used in this 
experiment was a mixture of the 3 major C isoforms, C1 (45%), C1a (35%), and C2 (30%) with an 
approximate molecular weight of 463.6 g/mol. The kanamycin was kanamycin A, which is the 
most commonly used variant and has a molecular weight of 484.5 g/mol. Amikacin is a derivative 
of kanamycin A and has a molecular weight of 585.6 g/mol. It is worth noting that the results 
previously published for dihydrostreptomycin (DHS) by Marcotti et al. in 2005 and in Van Netten 
& Kros 2007 were obtained under slightly different conditions (i.e. age and strain of mice, 
location along the coil), and thus may not be directly comparable to the results here. In this 







This chapter includes data recorded from 71 apical OHCs and 72 basal OHCs of P2+1 and P2+2 
cultured CD-1 wild type mouse cochleae. The average MET current size at -164 mV was  
-1.11 ± 0.003 nA in the apex, and -1.56 ± 0.004 nA in the base. The average resting MET current 
at -164 mV was 5.6% of the maximum in both the apex and base. This is smaller than the usually 
reported values of 10 to 50% (Farris et al., 2006; Beurg et al., 2010), possibly due to the negative 
pressure kept in the fluid jet which slightly pulls on the hair bundle, slackening the tip links and 
lowering the open probability. The largest MET current recorded was -2.29 nA in the apex, and 
-2.44 nA in the base. Average cell capacitance was 5.36 ± 0.01 pF in the apex and 5.03 ± 0.01 pF 
in the base, and average access resistance was 6.19 ± 0.02 M. Permeation modelling was done 
at -55 mV and 25C to match the approximate driving force on cells in experimental conditions. 
All modelling results are presented for a single open channel, thus with an open probability  
of 1.  
 
3.2.1 Block of MET current by three aminoglycosides 
All three AGs block MET channel currents in a generally similar manner to that reported for DHS 
by Marcotti et al. in 2005. Figure 3-2 shows examples of MET currents during control superfusion 
and during exposure to 30 M of each AG, recorded as described in sections 2.2.3 and 2.3. The 
outward currents at depolarising voltages are unaffected, but when the cell is hyperpolarised in 
the presence of each AG the large inward MET currents are strongly blocked. AGs could be 
quickly and fully washed out to recover full MET currents, as shown in figure 2-4. A comparison 
of the fractional block curves—calculated as described in section 2.3—at 30 M of each AG is 
shown in figure 3-3. All fractional block curves at each concentration and for each AG and coil 
are shown in figure 3-4. Figure 3-5 shows dose response curves at each voltage fitted with the 
Hill equation as described in section 2.4.1. The results of this fit are shown in figure 3-6.  
At the most negative membrane potentials a relief in block of the MET current was seen for all 
three drugs, indicating permeation of the drugs through the channel. The half-blocking 
concentrations (KD) varied significantly between drugs but were similar between apex and base. 
For all drugs, the KD increased dramatically and became meaningless at potentials above -24 mV 
as the drugs do not bind to the channel. These results are shown in Table 3-1. The Hill coefficient 
for all three drugs was approximately 1 in both apex and base and was therefore set to 1 in the 
























3.2.2 Kinetics of aminoglycoside block 
The temporal kinetics of the block by all three AGs was assessed in both apical and basal OHCs 
as described in the section 2.3. These results are shown in figure 3-7. The average time constant 
of full block upon channel opening at 10 µM for gentamicin was 0.50  0.18 ms (n = 6) in basal 
OHCs, which was similar to that previously described for DHS (Marcotti et al., 2005). Amikacin 
was faster but still relatively similar, with a time constant of 0.33  0.19 ms (n = 3). The time 
constant for kanamycin however was much faster than either gentamicin or amikacin, at  










3.2.3 Modelling results 
Fitting the fractional block curves with the two-barrier one-binding site model resulted in good 
fits as shown in figure 3-4. These fits, as well as the fits of the time constant data produced 
values describing the MET channel permeation pathway which are summarised in table 3-2. 95% 
confidence intervals are reported for parameters obtained from fitting the data. The remaining 
parameters are calculated as described in section 2.4.2. Data for the highest concentrations was 
more variable due to difficulties in acquiring stable recordings from such small currents. But 
excluding these points from the modelling only slightly affected the results so they were 
included. The apparent charge of the molecule with respect to the channel was approximately 
1.5-1.6 for gentamicin and kanamycin and was slightly higher for amikacin at 1.7 in the apex and 
1.8 in the base. The confidence intervals on these charges dictate that these differences are not 
significantly different from each other. The relative position and strength of the binding site 
within the pore are given by b and Eb, and the values for the energy barriers at the entrance 
and exit are given by E1 and E2 which are calculated from k1 and E. Using these values, energy 
profiles can be constructed that describe the relative position and strength of interaction of sites 
within the permeation pathway. These are shown comparing apex and base in figure 3-8 and 
comparing drugs in figure 3-11. 
 
3.2.4 Energy profiles and entry rates vary as a function of position along 
the cochlea 
The energy profiles show similar patterns between apex and base. For gentamicin and 
kanamycin, the apex had higher energy barriers at both the entrance and exit. For gentamicin 
and amikacin, the binding site position was shifted slightly towards the extracellular side in the 
apex. These parameters are closely linked to each other in the fitting process. Both the higher 
energy barriers and the shift in binding site will contribute to differences in entry rate, and it 
seems that in the model, each drug has its signature profile of how this difference is achieved. 
The entry rates for all three drugs saturated about 1.5-3 times lower in the apex than in the 
base. Interestingly, the entry rate for kanamycin in both the apex and base ultimately saturated 
at a much higher level than the other two drugs, which is likely due to its higher half-blocking 
concentration and faster time constants. This can be conceptualised as the drug interacting less 
with the channel as it passes through, thus both reducing its affinity at lower concentrations and 
then at higher concentrations making it more susceptible to the chemical driving force pushing 











3.2.5 Entry rates of the three aminoglycosides match their toxicity 
The comparative toxicity of gentamicin, kanamycin and amikacin in the basal turn of the 
neonatal cochlea was assessed. These experiments were performed by Ms. Cynthia Smith, and 
the relevant results shown in figure 3-10 were compiled by Dr. Richard Osgood. P2 cochlear 
cultures were incubated with varying concentrations of each AG for 48 hours, then fixed in 3.7% 
formaldehyde, permeabilised in 0.1% Triton X-100 and stained with Texas Red phalloidin and 
Rabbit -myosin VIIa, with a secondary stain of Alexa Fluor 488 Goat  Rabbit. Panels A-F of 
figure 3-10 show examples of basal OHCs at 30 M of each AG. The remaining hair cells in fixed 
basal regions of interest (ROIs) were counted. These results are quantified in panel G of figure 
3-10. The LD50 (determined by counting the number of OHCs that had both a cell body and a hair 
bundle) for gentamicin was 2 M, 36.1 M for kanamycin, and 167.1 M for amikacin. 
The entry rates (shown in panel B of figure 3-11) of all three drugs matched their relative toxicity 
in basal OHCs, with gentamicin being the most readily permeable, and amikacin the least. The 
LD50 concentrations and their matching entry rate are indicated as lines on panel B. This pattern 
is also reflected in the energy profiles (figure 3-11, panel A), which showed a similar staggering 
of strength at both the binding site and at the second energy barrier. Interestingly, the height of 
the first energy barrier was very similar for all three drugs.  
As mentioned, at high concentrations the relatively weaker affinity of kanamycin for the MET 
channel forces much higher concentrations of it through the pore and into the cell. However, 
over the concentrations that are relevant for the toxicity assays, its entry rate sits in between 
gentamicin and amikacin (figure 3-11). Additionally, the concentration at which the entry rate 
for kanamycin overtakes gentamicin (~5.5 M) is almost three times above the LD50 of 
gentamicin, so OHCs exposed to this concentration of gentamicin would certainly be dead and 
a difference in toxicity would not be evident. 
Entry rate in basal OHCs of gentamicin saturated at 500 molecules per second per channel, 1900 









3.3.1 What leads to the differences in permeation between apex and 
base? 
As discussed in section 1.2.5, there are many differences in the properties of the MET channel 
between neonatal apical and basal OHCs, the main ones being its number per cell, conductance, 
and genetic composition. The results presented in this study were modelled for entry through 
an individual open MET channel, thus controlling for a difference in channel number. In vitro and 
in vivo, an excess of channels in basal OHCs would further increase the differences in permeation 
between the two locations. But the relationship between channel conductance and drug 
permeation in these data is not immediately obvious.  
Because this experiment was not designed to address questions of TMC1 versus TMC2 but to 
relate AG entry to ototoxicity in cochlear cultures at the same stage of development, these 
results were obtained in wild type mice with uncontrolled levels of TMC1 and TMC2 in each coil.  
Thus, the present study can make no conclusions on the roles of TMC1 and TMC2 in the 
differences found in channel topology and permeation of aminoglycosides in the apex and base. 
However, it is worth noting that a previous study found that apical cells of Tmc2-/- (thus 
expressing TMC1 only) had a reduced permeation of DHS compared to wild types (Corns et al., 
2016). Another study found a higher calcium permeability for TMC2 versus TMC1 (Goldring et 
al., 2019), which is likely to be a closely related mechanism to the permeation of the polycationic 
AGs. According to previously published results, it is expected that at this stage the apex will 
express almost entirely TMC2 and the base will express mostly TMC1 (Beurg et all., 2018). Thus, 
a difference in permeation between TMC1 and TMC2 alone is not sufficient to explain the 
differences in permeation between apex and base for each drug presented here. 
Perhaps these results are indicative of two simultaneous gradients: as TMC1 has a higher 
conductance in the base than the apex (Beurg et al., 2018), TMC1 that is present in the base at 
this age must already have a higher permeability than TMC2 that is present in the apex. This 
suggests that the machinery setting up the gradient in single-channel conductance in OHCs along 
the cochlea is already present in the base in the early stages of TMC1 expression. Furthermore, 
though the energy profile is not a physical map of the channel, it describes its electrical topology 
and could be related to its shape and size. In this case, the differences noted in the height of the 
energy barriers and position and strength of the binding site could be indicative of differences 
between the pore topology of TMC1 and TMC2. This subject will be revisited in chapter 8 
following the presentation of further data. 
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3.3.2 What leads to the differences in permeation between the three 
drugs? 
It is at present unclear what causes these large differences in permeation between AGs. The Hill 
coefficient for each AG was close to 1 in both apex and base, so it can be safely concluded that 
gentamicin, kanamycin, and amikacin all bind non-cooperatively to a single binding site within 
the MET channel pore as was reported for DHS (Marcotti et al, 2005, Corns et al., 2016). 
Therefore, understanding the differences in permeation rates for each drug requires examining 
the factors that contribute to them and how they differ.  
As it is likely that the positive charges on the AGs are what allow them to permeate through the 
channel, a difference in charge interacting with the channel pore could explain differences in 
permeation rate. At a pH of 7.4, the electrical charges of gentamicin, kanamycin, and amikacin 
were measured by NMR spectroscopy to be 3.3, 2.4 and 2.8 respectively (Al Khzem, 2019). These 
do not appear to match the charges fit from the MET channel data here reported (approximately 
1.5 for gentamicin and kanamycin, and 1.75 for amikacin, though confidence intervals suggest 
these differences are non-significant), suggesting that the MET channel is only interacting with 
certain charges (perhaps even the equivalent charge point on each of the molecules), and not in 
a pattern consistent with either their entry rate or their measured charges. Furthermore, the 
charge of the molecules alone is not enough to account for the differences in permeation as 
fixing the charges to either 1.5 or 2 for all drugs did not drastically impact the entry rates.  
Perhaps a size restriction of the width of the molecules fitting through pore could explain the 
differential permeation. As previously discussed, the diameter of the narrowest part of the 
channel pore was determined to be ~12.5-15 Å (Farris et al., 2004; Alharazneh et al., 2011), but 
has recently been found to be potentially much larger (Desmonds, 2015; Ballesteros et al., 2018). 
Gentamicin, kanamycin, and amikacin are predicted to have maximum widths of approximately 
9.6 Å, 5.0 Å, and 8.0 Å, respectively. The size of the channel pore is therefore comfortably wider 
than even the largest AG studied, gentamicin, so it is unintuitive that differences in permeation 
are due only to a physical constraint. Furthermore, the difference in toxicity does not seem to 
correlate with the maximum width of each molecule, especially given the relatively small width 
of kanamycin. This small width does however possibly reflect the ability of kanamycin to pass 
through the pore with reduced resistance as evidenced by its higher saturation point than the 
other two AGs. The toxicity of the three AGs and their entry rates does match their ranking of 
molecular weights (see section 3.1), so it is therefore likely to be a combination of physical and 
biochemical factors that leads to differential permeation. 
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The energy profiles give an interesting perspective on how the drugs are interacting with the 
channel as they permeate. The k1 (rate over the first energy barrier) and Eb (binding energy) 
decrease and the E increases in accordance with toxicity for the three drugs. The relatively 
small differences in k1 are counterintuitive because of the large differences in temporal kinetics 
between the three AGs (especially for kanamycin, which had much faster kinetics than either 
gentamicin or amikacin as shown in figure 2-6 and figure 3-7). But despite this, k1 varies only 
minimally between the three drugs, thus producing similar values for the first energy barrier 
(E1). While the height of the E1 only changes minimally, the second energy barrier (E2) varies in 
height according to toxicity. E2 is calculated from E1 and E, and it appears that its height is 
reversely proportional to toxicity, perhaps providing more resistance to drugs entering the cell. 
This indicates that the restriction point leading to differential permeation is at the narrowest 
part of the pore, the exit. These findings further support the notion that the intracellular side of 
the pore is the narrowest (figure 1-9) (van Netten and Kros, 2007; Corns et al., 2016) and that 
differences in permeation of AGs could be related to their size and shape. 
 
3.3.3 Implications of variation in permeation for ototoxicity and 
otoprotection 
As the entry rates matched the toxicity differences both between drugs and between the apex 
and base, this indicates that the MET channel serves both as the primary entry route, and in a 
sense as the rate-limiting factor on ototoxicity. This strongly supports the effort to find 
otoprotectants that are reversible, ideally non-permeant, MET channel blockers. 
Of course, these results do not exclude the possibility that once inside the cell the AGs still enact 
varying intracellular pathways to cell death. The fact that the LD50 lines in panel B of figure 3-11 
do not match consistently with entry rate suggests that indeed there could be other additional 
factors contributing to differences in toxicity. It is perfectly reasonable to think that if these 
drugs are permeating differently through the MET channel, they may also for example permeate 
at different rates through mitochondrial membrane channels. Nevertheless, it is only logical that 
such large differences in permeation between AGs will lead to differences in intracellular AG 




3.3.4 Suggestions for future studies 
There are many experiments that could further elucidate the relationship between channel 
permeation and toxicity, and the differences between drug permeation in the apex and the 
base of the cochlea. These include: 
• Using TMC1 and TMC2 knockout mice to tease apart the contributions of each of these 
to AG permeation in apical and basal OHCs.  
• Investigating if the different isoforms of gentamicin, which have varying degrees of 
ototoxicity (O’Sullivan et al., 2020), also permeate differently through the MET channel.  
• As the channel number, temperature, and time in the permeation model can all be 
controlled, this allows the possibility of predicting the entry rate of AGs in vitro over 
time. Future experiments could use pulses of AGs over cultures for specified times to 
produce similar amounts of AG entry and check for their ototoxic effects.  
• Comparing permeation modelling data with newly available structural models of TMC1 
(Pan et al., 2018; Ballesteros et al., 2018) could give insight into the molecular correlates 
























Permeation of Gentamicin-Texas Red 




















GTTR is a fluorescently tagged conjugate of gentamicin and Texas Red that is used to visualise 
uptake of gentamicin into hair cells. Its uptake via the MET channel competes with native 
gentamicin, thus reducing ototoxicity in vitro and in vivo (Dai and Steyger, 2008; Wang and 
Steyger, 2009; Wang et al., 2010; Hailey et al., 2017). It is the use of GTTR that proved that hair 
cells required mechanotransduction for ototoxicity (Alharezneh et al., 2011). It has even been 
used to follow intracellular trafficking routes of gentamicin in hair cells (Hailey et al., 2017). 
Furthermore, the application of GTTR leads to a visible tonotopic gradient in fluorescent 
labelling like that found for several other compounds (figure 4-1) (Gale et al., 2001, Desmonds, 
2015), and similar to the toxicity gradient of native AGs (Kotecha and Richardson, 1994; 
Alharezneh et al., 2010; O’Reilly, 2019). Much care has been taken to demonstrate the functional 
use of GTTR as an indicator for gentamicin uptake in hair cells.  
Whilst GTTR certainly does seem to permeate through the MET channel, the question remains 
of how its permeation compares to native gentamicin. The addition of the Texas Red side chain 
makes it a much larger compound than gentamicin, with a maximum width of approximately 
14.7 Å (Alharazneh et al., 2011). According to early estimates of the MET channel pore width it 
would have been too narrow for GTTR to fit (Farris et al., 2004), but recent studies have shown 
compounds up to 23 Å to permeate now making GTTR permeation through the channel perfectly 
feasible (Ballesteros et al., 2018). However, during synthesis the Texas Red molecule binds onto 
and neutralises one of the potential regions of positive charge on gentamicin (figure 4-2). 
Because these positive charges are thought to contribute to binding of AGs to the channel 
binding site, this may impact permeation. Furthermore, it is now believed that the permeation 
pathway is in fact in the shape of a groove that contacts the cell membrane down one side 
(Ballesteros et al., 2018). This exposure to the hydrophobic tails of membrane phospholipids 
could interact with the lipophilic portion of the Texas Red molecule attached to gentamicin and 
affect the permeation profile and entry rate. 
To date only preliminary data have been acquired with regards to the electrophysiological 
interaction of GTTR with the MET channel and its behaviour as a channel blocker. I have 
therefore done a full permeation characterisation of GTTR in both apical and basal neonatal 
OHCs to compare it with gentamicin and to see whether the addition of the large, lipophilic 
Texas Red side chain affects it permeation through the MET channel. GTTR was obtained from 
Professor Peter Steyger (Creighton University) in dehydrated powder form (synthesised from a 










This chapter includes data from 16 apical OHCs and 14 basal OHCs of P2+1 and P2+2 cultured 
CD-1 wild type mouse cochlea. The average MET current size at -164 mV was -1.32 ± 0.005 nA 
in the apex, and -1.77 ± 0.007 nA in the base. The average resting MET current at -164 mV was 
approximately 3% of the maximum in both the apex and base. The largest MET current recorded 
was -1.93 nA in the apex, and -2.44 nA in the base. Average cell capacitance was 6.14 ± 0.02 pF 
in the apex, and 5.76 ± 0.02 pF in the base, and average access resistance was 4.69 ± 0.03 M. 
The data in this chapter were acquired and processed as described in chapters 2 and 3 with key 
differences where indicated. For instance, due to the slower kinetics of GTTR square waves of 
22 Hz (half the usual frequency) were used as a main protocol (figure 4-3). Sine waves were used 
in conjunction to check that stimuli were saturating. As in chapter 3, modelling was done at  
-55 mV to match the approximate driving force on cells in experimental conditions, and all 
results are presented for a single open channel, thus with a channel open probability of 1.  
 
4.2.1 Block of MET current by GTTR 
GTTR is a much more potent blocker than gentamicin, with approximately 10 times stronger 
block of MET currents. Its block is also reversible, like the AGs, but it can take longer to wash out 
and recover full current size. Fractional block curves for apical and basal OHCs are shown in 
figure 4-5, and corresponding dose response curves are shown in figure 4-6. As before,  
voltage-dependence of the KD and Hill coefficient were calculated for GTTR and results are 
shown in figure 4-7, and are summarised in table 4-1. Similar to gentamicin, GTTR also had a 
clear relief of block at strongly hyperpolarised voltages and is therefore certainly permeating 
through the MET channel. However, at depolarised potentials the block was relieved more 
gradually than any of the native AGs, indicating a much higher affinity for the channel and a 
reduced voltage-dependence of the interaction between the drug and the channel.  
Most intriguingly, the Hill coefficient for GTTR had an average of 2.5 at negative potentials, 
increasing slightly as voltage increases towards zero and then sharply dropping towards 1 at 
positive potentials. Because the modelling was done at -55 mV, the Hill coefficient was set to 
2.5. No apical to basal difference in KD or in Hill coefficient is apparent for GTTR, as was found 


























4.2.2 Kinetics of GTTR block 
The time constant of the decay in current is significantly different between gentamicin and 
GTTR, with block by GTTR developing at a much slower rate as shown in figure 4-8. A longer 
force step of 20 ms and occasionally 40 ms for low concentrations was therefore used to ensure 
that the entire decay curve could be accurately fit. The average time constant of full block upon 
channel opening by 1 µM GTTR in basal OHCs was 4.89 ms  1.01 ms (n = 12), approximately  
10 times slower than the 0.5 ms time constant of gentamicin reported in section 3.2.2. The slope 



















4.2.3 Modelling results 
Fitting of the fractional block curves with the two-barrier one binding-site model matched the 
data well. The results of this fit and the subsequent calculations are summarised in table 4-2.  
As expected, the apparent charge of the molecule was lower than for native gentamicin likely 
due to the Texas-Red side chain taking up one of the charge sites. Unlike any of the native AGs, 
the apparent charge was different in the apex and base at approximately 1.16 and 0.87, 
respectively. According to the confidence intervals on these values these differences in charge 
are statistically significant, but the reason for this is unknown.  
The striking differences in the behaviour of GTTR are evidenced by the energy profiles, shown 
in figure 4-7 (panel A). First, the binding energy for GTTR at the binding site is far stronger than 
it is for native gentamicin, at -34.4 kT compared to approximately -8.4 kT for gentamicin. 
Intriguingly, the binding site is also shifted towards the right in the apex whereas for native 
gentamicin it was shifted to the left. Most interestingly, the energy barriers in both the apex and 
base have negative values. This has never been reported before for any drug that has been 
tested with the MET channel. Mathematically, this result is related to the slow kinetics of block: 
E1 is negative because it is calculated from the log of k1, which is further exaggerated by the high 
Hill coefficient (see figure 4-8). This is interesting to compare with gentamicin and kanamycin, 
in that although kanamycin had about 10 times faster time constants than gentamicin, the slope 
of its time constants (and therefore k1) was still similar.  
The E is also much smaller than native gentamicin in both apex and base, and as for the binding 
site its apical to basal relationship is reversed compared to the native AGs. The significance of 
this is also unclear, but the fact the trend is reversed for several parameters suggests that this 
could be indicative of an altered mechanism of binding between GTTR and the MET channel 
compared to that for native AGs.  
Perhaps unsurprisingly, these differences in kinetics contribute to large differences in entry rate 
(table 4-2 and figure 4-7, panel B). As for the AGs, the apical channel permeates less GTTR 
compared to the basal channel. But unlike native gentamicin, GTTR appears to quickly saturate 









4.2.3 Entry rate and ototoxicity 
Whilst GTTR has a well-known tonotopic gradient in fluorescence (as shown in figure 4-1) and it 
has been extensively used as an indicator for gentamicin entry intro hair cells, little data has thus 
far been published on the ototoxic effects of GTTR itself. A dose-response curve for the toxicity 
of GTTR compared with gentamicin in basal OHCs was presented by Dr. Richard Osgood in his 
2019 thesis, which has been reproduced here with permission (figure 4-11). The methods for 
this experiment were as described in section 3.2.4, with exception that the quantification of hair 
cell survival was done from a phalloidin stain alone. The experiment was performed by Professor 
Guy Richardson and Ms. Jodi Parslow, and Dr. Richard Osgood quantified the data and created 
the graph.  
Although at first glance GTTR appears to permeate the channel far less than native gentamicin 
(as it certainly does at high concentrations!), at 1 M GTTR was modelled to have a slightly 
higher entry rate of 24.77 molecules per open channel per second, which was 23.38 for 
gentamicin. By 2 M, GTTR entry was 41.29 and gentamicin over-took with 44.68. GTTR entry 
then saturated at about 50 molecules per second around 3 M whilst gentamicin entry 
continued to climb and saturated at about 500 molecules around 100 M. This range of 
crossover between the entry rates of gentamicin and GTTR at low concentrations is shown in 
figure 4-11.  
In fact, in the dose response curve for basal OHCs GTTR was found to be slightly more ototoxic 
with an LD50 of 0.9 M, compared to 2 M for native gentamicin. Given that a margin of error is 
expected in these models of entry rate, and that the GTTR used in these two experiments came 
from different batches that could vary in purity, it is conceivable that at these low concentrations 
GTTR could indeed permeate more readily into the cell than native gentamicin, leading it to be 
more ototoxic in the same way as the native AGs presented in chapter 3. This higher permeation 
could be explained by its greater binding affinity for the MET channel, but further increasing of 
entry rate at higher concentrations is prevented by its large size.  
Once again, if a difference in permeation between gentamicin and GTTR does occur at these low 
concentrations, it is unlikely to fully account for their differences in ototoxicity. As before, if the 
interaction of GTTR with the MET channel is so different from native gentamicin then it is likely 
that its interactions with other intracellular targets will be different as well. For example, GTTR 
was found to induce formation of membranous blebs on the apical surface of cochlear hair cells 







Several things stand out from modelling GTTR permeation. First and foremost is the  
Hill coefficient which increases between 2 and 3 at low potentials, and then drops off sharply at 
high potentials. This Hill coefficient above 1 indicates that the drug may be able to bind to more 
than one site within the channel and that binding of multiple molecules to the channel may be 
cooperative. This cooperative binding appears to be voltage-dependent, as its effect reduces at 
higher potentials. This could be due either to a reduced affinity of the molecule for the channel, 
or perhaps even a voltage-dependent conformational change of the channel itself. A similar 
pattern was described by Gale et al. (2001) for the fluorescent dye FM1-43. The key difference 
is that FM1-43 was found to have an unusual ability to reside inside the closed MET channel, 
which was evidenced in the force steps as a slow development of current upon channel opening 
and slow inactivation of current upon channel closure (this also made it impossible to model 
FM1-43 permeation rate, which is expected to be very high). The observation that the MET 
currents in the presences of GTTR decline exponentially in response to force steps imply that 
GTTR is clearly an open-channel blocker and cannot reside in the closed channel. Additionally, 
FM1-43 was also found to be able to block both inward and outward currents. Extracellular GTTR 
does block some outward currents, but to a lesser degree than inward currents and generally its 
pattern of kinetics is more in line with the AGs than with FM1-43.  
The other striking observation is that the binding energy is approximately three-fold stronger 
for GTTR than for native gentamicin, and the energy barriers are both negative. This result is 
counterintuitive as an energy barrier should by definition be positive. There are several possible 
interpretations of this phenomenon, three of which I will outline here: 
1.) One caveat to the energy profile model is that there is no way to measure the width of 
the electrical field of the interaction sites, meaning that areas of charge within the 
channel pore could overlap. The energy barriers could appear negative in the model of 
GTTR because they are overshadowed by the intense negativity of the binding site. This 
would explain why the apical energy barriers appear “higher”–less negative–than the 
basal energy barriers, as they do for native gentamicin. 
2.) Another explanation is that according to our model, we believe that these energy 
barriers correspond to regions of positive charge at the entrance and exit of the pore. It 
is possible that the Texas Red portion of the molecule has negatively charged residues 
that bind to these two barriers, producing 3 distinct binding sites which are reflected in 
the Hill coefficient. Alternatively, new evidence suggests that there could also be areas 
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of negative charge at these points as well, which GTTR may be interacting with 
(Ballesteros et al., 2018).  
3.) Lastly, it is now believed that the channel pore is shaped like a groove down the side of 
the TMC1 protein, and that one side is in contact with the cell membrane (Ballesteros 
et al., 2018). It could be that the gentamicin portion of the molecule is going head-first 
into the channel pore and binding to the usual AG binding site before permeating into 
the cell, while the Texas Red portion is attracted to the lipophilic regions of cell 
membrane within the pore, effectively being “dragged” through the channel by 
gentamicin. This would cause it to block the channel more strongly than native 
gentamicin and could result in the higher binding energy and negative energy barriers.  
The dynamics of the interaction between GTTR and the MET channel could in fact be a 
combination of these three scenarios or could be due to a currently unknown property of the 
channel. It is at present unclear and warrants further study. Comparison of these modelling 
results with structural models of the TMC1 pore could help to elucidate the intriguing properties 
of the permeation of GTTR through the MET channel (see chapter 6 for more detail).  
The differences between apex and base for GTTR are interesting as well. Unlike the native AGs 
in which parameters were shifted in the apex to indicate a “narrower” pore, the trend is reversed 
in several of the parameters for GTTR. For instance, the apical binding site is further down the 
channel than the basal binding site, and the E is lower. And yet despite these differences the 
permeation is still predicted to be lower, likely due to the k1 which is lower in the apex than in 
the base. The reason why these trends are reversed is uncertain. Considering the three potential 
explanations outlined above, it is possible that a different mode of binding of GTTR to the 
channel pore—in some ways opposite—leads to an opposite trend between apex and base. The 
observation that the apparent charge is higher in the apex than in the base, unlike the native 
AGs, could also be indicative of a different mode of binding, perhaps between TMC1 and TMC2. 
(though as before the contributions of TMC1 and TMC2 to this effect cannot be conclusively 
commented on because wild-type mice were used in this experiment) 
What is most fascinating about these results is that despite the differences in kinetics, at low 
concentrations (1 - 3 M) the entry rates of gentamicin and GTTR are expected to be similar. As 
these are the concentrations that are regularly used in fluorescence uptake experiments and 
over which ototoxicity in culture can be assessed, this indicates that GTTR is a good marker of 
gentamicin entry into hair cells through the MET channel. Nevertheless, GTTR has kinetics 









Effects of Calcium, Maturation, and 
Driving Force on Aminoglycoside 



















The permeation profiles for native AGs presented in chapter 3 provide insight into how 
differences in permeation of these drugs may be related to their inherent ototoxicity, but these 
results are difficult to extrapolate to an in vivo situation for several reasons. The aim of this 
chapter is to explore some of the factors that affect AG permeation and how conditions in vivo 
may vary from experimental conditions, with the goal of providing an estimate of permeation 
rate for gentamicin through the MET channel in real adult hair cells. 
First and foremost, the calcium concentration in the endolymph is far lower than the perilymph, 
but for experiments that involve incubating hair cells for long periods of time we use a 
perilymph-like medium to keep cells alive. Thus, the experiments in chapter 3 and 4 were done 
in a “high” (1.3 mM) calcium medium to match the experimental conditions in toxicity assays. 
Calcium itself is a permeant blocker of the MET channel, thus lowering the calcium 
concentration in the superfusion medium produces several interesting effects. 1.) The MET 
currents increase in size, especially in the inward direction. 2.) The resting current as a 
percentage of total MET current increases as adaptation is reduced (Corns et al., 2014). 3.) As a 
blocker, calcium competes with AGs for the pore binding site. Lowering the calcium 
concentration increases the affinity of AGs for the channel, producing more block (Marcotti et 
al., 2005) (figure 5-1). Presumably this would increase the entry rate of gentamicin through the 
channel, as it was found to for DHS. To test this, I characterised the permeation profile for 
gentamicin in 100 M Ca2+ medium, the lowest possible without risking damage to tip links.  
Second, little is known about how AG permeation may change as hair cells mature, and the 
kinetics of the MET channel over the course of development are heavily debated. As previously 
discussed, there is a change in the profiles of TMC1 and TMC2 expression during the first 
postnatal week. In the apex at P2 it is expected that the MET channel is composed entirely of 
TMC2, and by P10 it should be entirely TMC1. A previous study by Corns et al. (2017) found that 
Tmc2-/- mice had a lower permeation of DHS through apical OHC MET channels compared to 
wild type. Furthermore, TMC1 is capable of faster calcium adaptation than TMC2 (Goldring et 
al., 2019), and TMC2 has a larger calcium permeability than TMC1 (Pan et al., 2013; Beurg et al., 
2015). Given that these properties are closely related, it would be interesting to see how 
maturation, which should produce a similar shift in expression profile from TMC2 to TMC1, 
might affect permeation of drugs through the channel. This could, moreover, elucidate 
differences in permeation between TMC2 and TMC1 and how these may impact the results 
presented in chapters 3 and 4. 
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However, recording MET currents is challenging to begin with and ordinarily recording MET 
currents from OHCs beyond the first postnatal week is almost impossible. In the neonates the 
OHCs stick together well and the flexibility of the organ of Corti allows it to maintain its shape 
during dissection. But as the mice mature, the organ of Corti becomes more rigid and less  
well-adhered and is therefore more easily breakable during dissection. The hair bundles 
especially become increasingly delicate as they anchor to the cuticular plate and the tectorial 
membrane. Removal of the tectorial membrane in older preparations is almost guaranteed to 
destroy the hair bundles.  
In order to study the effect of maturation on MET channel permeation, I used Tecta/Tectb-/- 
mutant mice to record from P9-P10 OHCs. These mutants completely lack a tectorial membrane, 
making recording MET currents possible at later ages. Even so, only apical OHCs could be 
recorded from as the basal part of the coil was too brittle to withstand dissection. I also recorded 
a new dataset for gentamicin in apical OHCs from P2 mice of the same strain to control for any 
inherent differences in permeation due to the Tecta/Tectb-/- mutation. Further adaptations to 
the experimental process were also made and will be described in section 5.3.1. 
Third, the permeation rate of molecules through the MET channel is dependent both on the 
extracellular concentration of drug and the voltage of the cell, which is different in culture than 
it is in vivo due to the endocochlear potential. In culture, the resting potential of OHCs is thought 
to range from -55 to -60 mV (Marcotti and Kros, 1999, Kirkwood et al. 2017), so the entry rates 
I have presented thus far were all modelled at -55 mV to allow for comparison with in vitro 
toxicity assays. In vivo, the resting potential of the OHCs is likely to be closer to -150 mV 
compared to the endolymph with the addition of the endocochlear potential (Mammano and 
Ashmore, 1996; Marcotti and Kros, 1999; Johnson et al., 2011). This large voltage difference will 
increase driving force on positively charged ions and molecules flowing into the cell and may 
also affect the binding properties of drugs with any voltage-dependent kinetics. Therefore, in 
section 5.4 of this chapter I will show each of the permeation datasets presented thus far in this 
thesis, but now modelled as a function of both concentration and voltage. This will demonstrate 
the cooperative effects of voltage and concentration on permeation through the MET channel 
and how the topology of permeation changes with driving force for each drug and condition.   
Finally, I will discuss the interplaying effects of the results of these experiments, and what these 
results may indicate for permeation in an in vivo adult OHC. It should be noted that the 
completion of these experiments was cut short by the COVID-19 crisis, and therefore some data 
are missing where indicated and errors may be larger than usual.  
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5.2 Effect of calcium on gentamicin permeation 
This section includes data from 12 basal OHCs of P2+1 and P2+2 cultured CD-1 wild type mouse 
cochleae. The data in this section were acquired and processed as described in chapters 2 and 
3, with the exception that recordings were made in superfusion medium containing 100 M Ca2+ 
instead of the regular 1.3 mM Ca2+. Because of this, some differences are apparent in MET 
current characteristics as previously discussed. The average MET current size at -164 mV was  
-1.71 ± 0.007 nA, and the average resting MET current at -164 mV was 15 ± 0.2% of the maximum 
in both apex and base. The largest MET current recorded was -2.05 nA. The average cell 
capacitance was 5.5 ± 0.02 pF, and average access resistance was 8 ± 0.10 M. As in chapter 3, 
entry rate modelling was done at -55 mV to match the approximate driving force on cells in 
experimental conditions, and all results are presented for a single open channel, thus with a 
channel open probability of 1. The solution in the fluid jet was set to low calcium to further avoid 
mixing of low and high calcium in the immediate extracellular environment.  
 
5.2.1 Block of MET currents by gentamicin in low calcium medium 
As expected, lowering the calcium concentration of the superfusion medium increased the size 
of the MET currents, increased the fraction of the MET current activated at rest, and increased 
the strength of gentamicin block on the MET currents. These properties are all illustrated in 
figure 5-1.  
Quantification of the block (shown in figure 5-2 and summarised in table 5-1) by fitting dose 
response curves showed that the Hill coefficient remained the same as in regular calcium, at 
about 1 across voltages. A large shift in KD was apparent so that gentamicin blocked MET 
currents by half at a much lower concentration when less calcium was present (table 5-1). 
Voltage-dependent relief of the block upon depolarisation was more acute in low calcium 
medium, so that by -24 mV there was almost no block of MET current (for this reason this voltage 

























5.2.2 Kinetics of gentamicin block in low calcium medium 
The temporal kinetics of the block by gentamicin in 100 M Ca2+ medium closely resembled 
those in 1.3 mM Ca2+ medium but were slightly faster, and the slope (equal to the rate constant 













5.2.3 Modelling results 
The differences in KD and k1 between gentamicin in regular medium and in low calcium medium 
led to differences in the energy profile and permeation rate through the channel (shown in 
table 5-2, figure 5-5). As was found for DHS, the first energy barrier was lower in low calcium 
medium, but the second energy barrier was unaffected due to a complementary lower E 
(Marcotti et al., 2005). This makes sense as the extracellular calcium concentration would affect 
the rate over the first energy barrier but would not affect the second energy barrier which is 
closer to the intracellular side of the pore.  
Intriguingly, the apparent charge was higher for gentamicin in low calcium medium. The binding 
site was also shifted towards the intracellular side of the pore compared to in regular calcium 
medium, which is unlike previous results found for DHS. This is likely because in the 2005 study 
the authors fixed the charge of DHS to 2 for all conditions, whereas I left it as a free parameter 
in the two-barrier one-binding site fit. Fixing the charge to 2 for gentamicin in both conditions 
produced a similar shift so that the binding site in regular calcium became 0.86 ± 0.07, and it 
became 0.88 ± 0.1 in low calcium. The apparent charge therefore has a strong impact on the 
position of the binding site in the energy profile, which is why I left it free for all of my energy 
profile comparisons.  
According to my modelling results, the entry rate through the MET channel for gentamicin in 
low calcium medium was over twice as high as it was in regular calcium, saturating at almost 









5.3 Effect of maturation on gentamicin permeation 
This section includes data from 10 apical OHCs of P2 and 12 apical OHCs of P9-P10 acutely 
dissected Tecta/Tectb-/- mutant mouse cochleae. The average MET current size at -164 mV in  
P2 OHCs was -0.98 ± 0.01 nA and was -1.90 ± 0.006 nA in P9-P10 OHCs. The average resting MET 
current at -164 mV was 2.6 ± 0.03% in P2 and was larger at 9.4 ± 0.001% in P9-P10 OHCs.  
The largest MET current recorded was -1.72 nA in P2 OHCs and -2.49 nA in P9-10 OHCs.  
The average cell capacitance was 6 ± 0.02 pF in P2 OHCs and increased to 6.73 ± 0.01 pF in  
P9-P10 OHCs, and average access resistance was 5.32 ± 0.04 M. Aside from the specific 
adaptations mentioned in the following section, the data in this section were acquired and 
processed as described in chapters 2 and 3. As in chapter 3, modelling was done at -55 mV to 
match the approximate driving force on cells in experimental conditions, and all results are 
presented for a single open channel, thus with a channel open probability of 1.  
 
5.3.1 Adaptations to methods for P9-P10 recordings 
Adaptations to the dissection and recording procedure were made in order to record from P9-
P10 OHCs. Only the very most apical part of the apical coil (~5-8 kHz) could be recorded from 
due to instability of the basal turn. Great care was taken during dissection to avoid stretching of 
the coil as this would distort and break the organ of Corti (which was far more rigid and delicate 
than in the neonates). The superfusion flow pressure was reduced by lowering the level of the 
syringes by about 1 cm, which was necessary as the cells were less adherent to one another and 
risked being blown away or disrupting the patch pipette seal while changing superfusion lines. 
The amplitude of the fluid jet stimulus was reduced by half, as the hair bundles were more 
delicate and needed far less stimulation to produce saturating MET currents—in fact, the usual 
fluid jet amplitude tended to immediately destroy the hair bundles. No surface cleaning of the 
cells was necessary as the basolateral membranes of the OHCs were already exposed 
immediately after dissection.  
Data collection for this experiment was cut short due to the COVID-19 crisis. As such data for 
the lowest and highest concentrations of the dose response curve for the P9-P10 dataset could 
not be collected in time for submission of this thesis (figure 5-8, panel B). Whilst not ideal, this 
should not drastically affect the fit of the curve as the upper and lower bounds of the Hill 
equation fit are routinely fixed to 1 and 0 respectively, and the Hill coefficient is fixed to 1 for all 
native AG datasets.  
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5.3.2 Block of MET current by gentamicin in P9-P10 OHCs 
Following adaptations to the dissection and recording procedure as described, large MET 
currents could be elicited from P9-P10 apical OHCs of Tecta/Tectb-/- mutants with relative ease. 
An example of these is shown in figure 5-6 (panels C and D). Membrane seals on OHCs were 
easy to form and stable, though MET currents tended to deteriorate relatively quickly during 
experiments probably due to the increased fragility of the hair bundles compared to neonatal 
OHCs.  
The block of MET currents was quantified by fitting the dose response curves (figure 5-8) as 
before and was found to be different in the P9-P10 OHCs compared to P2 (figure 5-9). The Hill 
coefficient for gentamicin was again close to 1 across voltages at both ages, but unlike in any of 
the previous datasets the KD was higher in P9-P10 OHCs. This is also unlike the difference in 
results found previously for immature Tmc2-/- OHCs, which showed an increased block by DHS 
(Corns et al., 2017). Interestingly, voltage-dependence of the block was again much steeper in 


























5.3.4 Kinetics of gentamicin block in P9-P10 OHCs 
The time constants for gentamicin in P9-P10 OHCs were much faster (as is often observed for 














5.3.4 Modelling results 
Comparing the acute apical P2 dataset in Tecta/Tectb-/- mutants to previous results for acute 
apical OHCs in wild type CD1 mice shows that the Tecta/Tectb-/- mutation does not drastically 
impact the permeation rate of gentamicin through the MET channel. Minor differences can be 
accounted for by smaller N numbers due to cut-off of the experiment by COVID-19. As such 
these datasets can be safely compared.  
The energy profile of the MET channel had some interesting differences between P2 and P9-P10 
OHCs, as shown in table 5-4 and figure 5-11 (panel A). The first energy barrier was higher in  
P9-P10 OHCs due to the lower k1, but the second energy barrier was almost identical at both 
ages due to a difference in E. In P9-P10 OHCs the apparent charge was lower, and the binding 
site was shifted to the left. This shift is in the opposite direction to what would be expected if 
the results in permeation between apex and base presented in chapter 3 were representative 
purely of a difference in permeation between TMC1 and TMC2.  
The entry rate for gentamicin in P9-P10 OHCs was lower than it was for P2 OHCs (figure 5-11, 
panel B). This agrees with previous results found in Tmc2-/- OHCs in which a lower entry rate per 
channel was found than in wild type OHCs (Corns et al., 2017). This difference in permeation is 
likely to be due to TMC2 having a slightly larger N-terminal domain which could affect the 
entrance energy barrier and calcium selectivity (Goldring et al., 2019). Furthermore, this again 
supports the results from chapter 3 for which I suggested that a difference in TMC2 and TMC1 
alone was not enough to account for the difference in permeation found between apex and base 
in neonates. There must therefore be an additional gradient in permeation of TMC1 of apical 
and basal MET channels, in accordance with its gradient in single channel conductance 
(Ricci et al., 2003; Beurg et al., 2006; Fettiplace and Kim, 2014; Beurg et al., 2015; Beurg et al., 
2018). Given that TMC2 is thought to have little to no gradient in conductance along the 
neonatal cochlea (Beurg et al., 2018), it is therefore likely that TMC2 would have a similar lack 









5.4 3-dimensional entry rate modelling 
For simplicity, the models of permeation rate shown thus far have all been represented as a 
function of concentration at a fixed voltage of -55 mV. This allows for comparison with toxicity 
assays in which the cells rest in culture at approximately -55 mV and the concentration of drug 
they are incubated in is experimentally varied. It is important to bear in mind that in a hair cell 
in situ in the cochlea, the cooperative effects of both voltage and concentration on driving force 
will affect permeation of drugs through the MET channel. The addition of the endocochlear 
potential will increase the driving force at rest to approximately -150 mV, and as the cells are 
active their electrical potential will constantly change. Therefore, in order to gain a broader 
understanding of permeation as it may occur in vivo, figures 5-12 through 5-17 show each 
dataset thus far presented in this thesis modelled as a function of both voltage and 
concentration. These reveal similarities and differences between the permeation profiles of 
different drugs and conditions.  
For example, the 3 native AGs look similar except for differences in the scale of the Y axis. 
Kanamycin (figure 5-13) is “pointier”, so even though it can reach entry rates much greater than 
gentamicin (figure 5-12), it is more susceptible to driving force and only does so at the lowest 
voltages and highest concentrations. Kanamycin and amikacin (figure 5-14) look particularly 
alike except that the scale of the Y axis is much larger for kanamycin. Comparing these molecules 
this way highlights that the modification made to kanamycin to produce amikacin makes it less 
permeant through the MET channel. This could guide the future redesign of AGs that permeate 
less and are therefore less ototoxic.   
As expected, the topology of GTTR permeation is very different to that of the native AGs  
(figure 5-15). In fact, in this figure the voltage is represented on a different scale, from -200 to 
200 mV. The saturation of the block is clear at relatively low concentrations but lowering the 
voltage can continue to increase permeation.  
The permeation profile of gentamicin in low calcium medium (figure 5-16) is uneven at high 
voltages and low concentrations, reflecting the sharper voltage-dependent relief in block. 
Permeation is consistently higher than in regular medium, but interestingly at the lowest voltage 
and highest concentration modelled (-200 mV and 1000 M), the entry rate is very similar. The 
reason for this is unknown. The permeation profile of gentamicin in P9-P10 OHCs (figure 5-17) 
looks almost identical to that of P2 OHCs but a little lower, indicating that permeation of TMC1 


















With the results of these and my previous experiments I can make a prediction for the entry rate 
of gentamicin in apical and basal cells of a mature mouse cochlea. To summarise, the main 
factors that will influence entry rate of drugs into hair cells through the MET channels are: the 
concentration of drug, the membrane potential, the temperature, the resting open probability, 
the number of channels per cell, the location along the coil (as evidenced by the results in 
chapters 3 and 4), and the concentration of calcium. These first five parameters can be taken 
from the literature and the final two conditions can be extrapolated from my data.  
The best estimate of a physiologically relevant concentration for AGs in the endolymphatic space 
that will cause ototoxicity is approximately 1 M (Tran Ba Huy et al., 1981; Marcotti et al., 2005). 
Furthermore, according to toxicity dose response data this is slightly below the LD50 in the basal 
turn, so should cause a low level of toxicity to basal OHCs probably similar to that seen in 
patients. In a mature animal, the endocochlear potential is expected to produce a driving force 
of approximately -150 mV into the hair cells (Mammano and Ashmore, 1996; Marcotti and Kros, 
1999; Johnson et al., 2011), and the body temperature of a mouse would be approximately 36C. 
Given that my measurement of resting open probability of 0.15 in low calcium may be slightly 
low due to the negative pressure of the fluid jet, I will set it to 0.3, at the point of maximum 
sensitivity of the MET channel and to allow for comparison with results for DHS from Marcotti 
et al., 2005.  
The number of channels per hair cell is a question fraught with controversy. The main issue lies 
with the definition of a single channel, as recent evidence suggests that each MET channel 
complex may contain a variable number of TMC1 dimers, each with their own permeation pore 
(Beurg et al., 2018). Given that these multiples of TMC1 (if they do exist) are likely to be closely 
cooperatively gated, disentangling what is a single channel from a single pore becomes 
complicated. Additionally, it has long been thought that there are two MET channels per tip link 
(each anchored to the two bottom strands of PCDH15) (Beurg et al., 2006). If, for simplicity, in 
our model we consider a single channel to be equivalent to a channel complex including its 
potential multiple TMC1 pores, we can estimate the number of channels as twice the number 
of tip links per hair cell, which is different between the apex and base. There are about 50 tip 
links per apical cell and 60 tip links per basal cell, meaning that there are likely to be 
approximately 100 channel complexes per apical cell and 120 per basal cell (Beurg et al., 2006). 
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The controversy surrounding single MET channels and how this relates to our model will be 
discussed again in chapter 8.  
Using these factors, I can extrapolate an entry rate in vivo from my mature and low calcium 
datasets. As the Tecta/Tectb-/- mutation does not appear to change MET channel permeation 
and the drop in permeability of gentamicin at P9-P10 agrees with what was previously found for 
DHS in Tmc2-/- mutants (Corns et al., 2017),  I can use the P9-P10 dataset as an indication of 
permeation in mature apical wild type OHCs. The basal OHCs are expected to have fully matured 
by the age in which my basal experiments were conducted (Lelli et al., 2009), so I can therefore 
use the low calcium dataset as an indicator of entry rate in mature basal OHCs in the presence 
of the endolymph. I can calculate a scaling factor of how low calcium will affect permeation by 
dividing the entry rate in low calcium by that in regular calcium of basal OHCs and apply this 
factor to the P9-P10 dataset to predict the entry rate in endolymph. Finally, I can multiply these 
predicted entry rates by the number of channels to get an estimate of entry rate per cell per 
second in both mature apical and basal OHCs in vivo.  
First, I calculated an entry rate for gentamicin in low calcium at 1 M, -150 mV, and 36C, with 
a resting open probability of 0.3. This produced an entry rate of 210.2 molecules per second per 
channel. Comparing this with entry rate for the same parameters in the regular calcium dataset 
(47.7) shows that the low calcium medium scales the entry rate at 1 M by a factor of 4.40. 
Multiplying the entry rate for the P9-P10 dataset, which is 9.6 molecules per second, by this 
scaling factor gives 42.4. Multiplying each of these two values by the number of channels in each 
location (100 and 120, respectively) gives 4245 molecules per second in an apical cell and 25227 
in a basal cell.  
This entry rate of 4245 in mature apical hair cells is a little lower than the 9000 molecules that 
were predicted for DHS in neonatal apical cells (Marcotti et al., 2005). For direct comparison, 
the same prediction for gentamicin in my neonatal apical wild type OHC dataset produces an 
entry rate of 8140 molecules per second, almost identical to DHS.  
To conclude, these calculations predict that over 6 times more gentamicin will permeate into 
high frequency cells than low frequency cells of the adult cochlea. This shows that basal cells 
will be flooded with gentamicin compared to apical cells and leaves little room for doubt that it 
is primarily permeation through the MET channel that makes the hair cells more susceptible to 
ototoxic drugs than any other route of uptake. This also explains why patients who experience 
drug-induced ototoxicity selectively lose their high frequency hearing. 
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Despite extensive characterisation of the kinetics of the MET channel and its permeation profile, 
we still are unsure of the molecular correlates for the interaction sites of drugs permeating 
through the channel. In fact, at the start of this thesis the identity of the MET channel was still 
unknown, and only very recently has its main pore-forming subunit been identified as TMC1 
(Ballesteros et al., 2018; Pan et al., 2018). This identification presents new opportunities to 
further probe the permeation pathway and to potentially pinpoint residues within the protein 
that correspond to the interaction sites predicted by our model. Furthermore, the MET channel 
is a large complex with multiple subunits, others of which might interact with TMC1 and affect 
its permeation kinetics. The goal of this chapter is therefore to address how certain genetic 
aspects of the channel may affect our permeation model. Sections 6.2 and 6.3 of this chapter 
include data from collaboration with the two groups responsible for proving the MET channel 
pore identity. Section 6.2 will discuss how structural modelling of the channel can inform and 
complement biophysical modelling, and section 6.3 will describe a project designed to probe the 
role of the residues lining the pore in channel permeation, including one which could potentially 
be our predicted binding site—D569. Section 6.4 will present the results of an experiment 
assessing the influence of ASIC1b, a potential MET channel complex candidate, on the calcium 
permeability of the pore.  
 
6.2 Structural modelling of the TMC1 pore  
In 2018, Ballesteros et al. produced a model of the structure of TMC1 based on homology 
modelling with TMEM16, which revealed the presence of a large anionic cavity built by 
transmembrane helices 4-7 that could serve as a permeation pore. Following a discussion at the 
Association for Research in Otolaryngology MidWinter meeting in January 2020, I contacted  
Dr. Ballesteros to ask if she could provide insight into how her structural data might correspond 
with our experimental permeation data. She responded by very kindly offering to produce a 
series of customised figures that would highlight the areas within the TMC1 protein of particular 









This structural model reveals some fascinating aspects of the MET channel permeation pathway. 
Panel A shows the TMC1 dimer as it is thought to assemble, with the two TMC1 chains coloured 
in purple and blue, respectively. Panel B focuses on chain A looking through the side of the 
molecule and into the pore. This shows the areas of negative and positive charge lining the 
channel pore, with negatively charged residues coloured in light blue and positively charged 
residues in red. This pore structure can be compared with panel B of figure 1-9 showing our 
schematic model based on the energy profile of the interaction with DHS (Corns et al. 2016), 
which my results in chapters 3 and 5 further corroborate. Comparison of these models reveals 
that the area of negative charge near the bottom end of the pore corresponds to the predicted 
location of our AG binding site (though this prediction was made from the energy profiles of AG 
interaction which represent electrical distance and may not map directly onto physical distance). 
The negative residue D569 is highlighted in green and will be discussed in further detail in section 
6.3. There are also areas of positive charge near the entrance and exit of the pore which 
correlate well with our two predicted energy barriers. The shape of the pore fits with our 
expectation, i.e. a narrow entrance with a large cavity in the bottom region, and an even 
narrower exit. This demonstrates how differential permeation of AGs may be due to size 
restriction at the exit—our second energy barrier—of the pore.  
Most intriguingly, there are additional areas of negative charge around the entrance and exit.  
In fact, this results in 3 distinct areas of negative charge, which could be related to the Hill 
coefficient of almost 3 calculated for GTTR permeating through the channel. This raises the 
possibility that if GTTR could in fact bind to these areas, then potentially so could other 
molecules. So, although our model appears to neatly describe the method of binding of the 
native AGs, it could be incomplete and other molecules could have modes of binding that we 
are not yet aware of. For example, this could explain the mechanism by which FM1-43 
permeates (Gale et al., 2001), which is clearly very different to the AGs. Given the shape of the 
pore it is evident how FM1-43 might be able to reside inside the closed channel: the cavity is 
quite large, and FM1-43 is a long and thin molecule. 
Finally, panel C shows a cross-sectional view of the channel at the level of the D569 residue, 
revealing a C-shape of the pore with cell membrane contacting one side (as described in 
Ballesteros et al., 2018). This suggests further possibilities for why GTTR may saturate the 
channel so readily and exhibit an unusual binding profile, as the Texas Red side chain may be 
“dragging” through the side of the membrane.  
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6.3 TMC1 pore mutation D569C 
6.3.1 Introduction 
The Holt group, jointly based at Boston Children’s Hospital and Harvard Medical School, have 
developed a series of viral vectors that contain point mutations of 17 residues of TMC1 to 
cysteine. These vectors can be injected into Tmc1-/-/Tmc2-/- early neonatal mice, leading to 
expression of selectively mutated TMC1 within the first few days of development. It was by using 
this method that the Holt lab was able to prove that TMC1 is the pore-forming subunit of the 
MET channel, and the results were published Cell in 2018 (Pan et al., 2018). As these TMC1 point 
mutations would be ideal for teasing out the contributions of charged residues to the 
biochemical interaction between the channel and the ototoxic drugs that permeate it, we 
contacted the Holt lab to ask if they would be interested in a collaboration, to which they agreed.  
I went to visit the Holt lab in Boston for two weeks in March 2019 to acquire preliminary data 
towards developing the project. For the scope of the trip we decided to focus on just one pore 
mutation, D569C. There were several reasons for this choice, primarily that aspartic acid (D) is 
negatively charged making it a candidate for the AG binding site in our model. According to the 
electrophysiology data in Pan et al. (2018), full-sized MET currents can still be elicited from 
D569C mutants in IHCs, but the currents are reduced by application of MTSET (which binds 
irreversibly to cysteine) indicating that the residue faces the interior of the pore. In the 
supplementary data, they found that D569C in the utricular MET channels reduced the potency 
of the block by DHS. Furthermore, recent evidence by the Fettiplace group shows that D569N 
mouse mutants have a reduced calcium permeability compared to wild type (Beurg et al., 2019). 
At the time the exact location of the residue within the pore was uncertain, but it was thought 
to be at the lower end of the cavity, further supporting it as a prime candidate for the AG  
binding site. 
I originally aimed to do both electrophysiology in IHCs (as the uptake of the viral vectors is better 
than in OHCs) and immunolabelling experiments. I wanted to probe the affinity of gentamicin 
for the D569C MET channel in IHCs (and ideally calculate an entry rate!), but two weeks proved 
too little time to acquire enough viable physiology data on an unfamiliar setup. The other 
experiment aimed to see whether the D569C mutation would protect hair cells from ototoxicity 
of gentamicin over a 48 h period. This did yield some results, though at present the results are 




In preparation for the trip, we determined that a concentration of 30 M gentamicin for 48 h 
would be the minimum required to produce full ototoxicity of IHCs (which are less sensitive than 
OHCs), making any protection conferred to IHCs by reduced uptake of gentamicin evident. Prior 
to my arrival, a litter of Tmc1-/-/Tmc2-/- mouse pups were injected at P1 with the  
AAV2/1-CMV-Tmc1ex1-D569C viral vector via the round window membrane (left side only) 
(Askew et al., 2015; Pan et al., 2018). Three Tmc1D569C-injected pups and two wild type pups 
were dissected at P5 and the apical and basal turns of the cochleae were cultured separately for 
24 hours through a similar process to that described in chapter 2 (fully described in Pan et al., 
2018). 3 wild type and 3 Tmc1D569C cultures were incubated in 30 M gentamicin for 48 h.  
FM1-43FX, a fixable analogue of the fluorescent dye FM1-43 was briefly applied (~10 sec) to the 
cultures and washed out. FM1-43 rapidly enters the hair cells through the MET channel (Gale et 
al. 2001) and is often used as an indicator of functional mechanotransduction. The cultures were 
then fixed in 3.7% formaldehyde for 1 h, permeabilised in 0.1% Triton X-100, and stained with 
Rabbit  myosin VIIA overnight. A secondary stain of phalloidin 647 and Goat  Rabbit 555 was 
applied for 1 h, and the cultures were then mounted and imaged by confocal microscopy. 
 
6.3.3 Results 
The results of this experiment are shown in figure 6-2. It is clear that 30 M gentamicin is 
sufficient for destroying the majority of hair cells in the wild type culture (panel B). It appeared 
that the Tmc1D569C cultures incubated with gentamicin suffered no hair cell lost at all, in any of 
the 3 cultures tested and in either the apical or basal turn. However, though great care was 
taken (and the same batch had been successfully tested by a lab member earlier in the week), 
the FM1-43FX did not produce any signal under confocal microscopy. Without this signal it was 
not possible to conclusively determine whether the Tmc1-/-/Tmc2-/- cultures were expressing the 
injected Tmc1D569C, thus the protection observed could be due to a lack of functioning 
mechanotransduction and not protection conferred by the D569C mutation. However, to follow 
up on this an acute dissection of a mouse from the same litter (now P11) that had also been 
injected with Tmc1D569C was made and native FM1-43 was applied to test whether this littermate 
had functional MET channels. FM1-43 labelling after 30 seconds could be strongly viewed under 
upright dissection microscope, indicating that the MET channels were in fact functional in this 
littermate and were likely to also be functional in the cultures presented in figure 6-2. 







Based on the reduced sensitivity to DHS of utricular MET currents (Pan et al., 2018, 
supplementary figure S13), we estimated that the D569C mutation should halve the toxicity of 
30 M gentamicin applied for 48 hrs in IHCs. In fact, the protection observed was stronger than 
anticipated, so that no gentamicin damage was seen in any Tmc1D569C cultures. Thus, without 
the FM1-43 signal to prove expression of Tmc1D569C it is difficult to say whether the cells were 
protected by the mutation or whether they were protected due to their lack of functional MET 
channels. Subsequent application of native FM1-43 to an acute cochlea taken from a co-injected 
littermate provided anecdotal indication that the results were genuine.  
The preliminary data acquired during my trip to Boston are promising, but they are only a scratch 
on the surface of the experiments that would be made possible by this project. Repetition of 
this experiment as well as electrophysiological characterisations of TmcD569C cells could reveal 
the exact role of the D569 residue in AG binding and permeation through the MET channel. 
Furthermore, in their study, Pan et al., (2018) describe several other residue mutations that 
were found to have profound impacts on transduction and were likely to line the pore of the 
MET channel, and many of these are charged. For example, another aspartic acid-to-cysteine 
mutation, D528C, had a massive reduction in steady-state MET currents even before the 
addition of MTSET. The structural model in panel B of figure 1-9 suggests that the D528 residue 
is located near the entrance of the pore and could be part of the region of negative charge seen 
in this region in figure 6-1. The reason for its drastic effect on MET currents upon mutation would 
be very interesting to investigate, especially given that our model does not predict a negative 
charge at this location. It could be playing a crucial role of balancing charge in that region, 
without which the first energy barrier could be too strong to let anything through, even cations. 
Other mutations with a strong impact on channel currents include G411C, T532C, N447C, and 
M412C (Pan et al., 2018). This final mutation is on the same residue as the Beethoven mutation, 
which was also previously found to have a reduced sensitivity to DHS when mutated to lysine 
(Corns et al., 2016). The contribution of each of these pore-lining residues could be assessed for 
their impact on the permeation profile of AGs, and by this method we could determine exactly 
how drugs are moving through the channel and what biokinetic property of the channel makes 
gentamicin more permeant than amikacin, for example. Furthermore, we could assess whether 
the channel might have voltage-dependent changes in configuration suggested by drugs with a 




6.4 The role of ASIC1b in calcium permeability 
6.4.1 Introduction 
Expression of the acid-sensing ion channel 1b (ASIC1b) has been discovered in hair cells (Ugawa 
et al., 2006; Ugawa et al., 2008) but its function is uncertain. A previous lab member discovered 
the presence of a current in the IHC membrane that could be elicited by drops in extracellular 
pH (Roberts, 2013). As their name implies, ASICs conduct cations in response to increases in 
proton concentration. ASIC1b was therefore considered to potentially be responsible for this 
acid-sensitive current, but the same current could be elicited in Asic1b-/- IHCs (Roberts, 2013). It 
is possible that other ASIC variants may also be expressed in hair cells and could be functionally 
redundant, thereby compensating for lack of ASIC1b. However, so far there has been no 
evidence for this. 
Furthermore, ASIC1b has been localised to several parts of the hair cell body, and in the 
stereocilia. Its presence near the ankle links led to a hypothesis that it could be part of the 
unconventional MET channel (responsible for reverse-polarity currents observed during 
mechanical stimulation of the OHC membrane following deterioration of the tip links) (Ugawa 
et al., 2006), but the identification of PIEZO2 as responsible for these currents renders this 
unlikely (Beurg and Fettiplace, 2017). More recently it was found at the tips of the stereocilia, 
suggesting involvement in mechanotransduction (Ugawa et al., 2008). If it is a part of the MET 
channel complex, its role remains unknown. Like the MET channel, it forms a potentially 
mechanosensitive pore that is permeable to K+ and blocked by amiloride (Rüsch et al., 1994; 
Ugawa et al., 2008). It was therefore considered a potential candidate for the pore of the MET 
channel, but subsequent confirmation of this role by the TMCs renders this hypothesis doubtful.  
To determine whether ASIC1b is involved in MET channel permeation and to further our 
understanding of its role in hair cells, I investigated whether the Asic1b-/- mutation affects the 
instantaneous calcium permeability of the MET channel. This experiment involved recording 
MET currents under superfusion of a high calcium solution with no other free cations present 
either extra- or intra-cellularly and determining the membrane potential at which the flow of 
current carried by calcium reverses. If the permeability of calcium has been affected by the 
removal of ASIC1b, then the reversal potential should be shifted as was found for the TmcBth/Bth 
mutation (Corns et al., 2016). A negative result for this experiment would almost definitely 




The data in this section were acquired and processed as described in chapter 2, with some slight 
differences. In this experiment, a modified superfusion solution was used containing (in mM): 
100 CaCl2, 20 N-methylglucamine, 6 Tris, 10 D-glucose (adjusted to pH 7.4 with HCl, osmolality 
~300 mOsmol kg-1). A modified intracellular solution was also used, containing (in mM): 135 CsCl, 
3 MgATP, 10 Tris phosphocreatine, 1 EGTA-CsOH, 10 HEPES-CsOH (adjusted to pH 7.2 with CsOH, 
osmolality ~295 mOsmol kg-1). These solutions were designed to restrict the passage of cations 
through the MET channel to calcium only (as in Corns et al., 2016). Voltage-step protocols from 
both -164 mV to +96 mV in 20 mV steps, and from -84 to +76 mV in 10 mV steps were used, with 
a sine wave stimulation of 45 Hz in both. The first protocol was used to allow comparison with 
other experiments and to show maximal current sizes (as in figure 6-3). The latter protocol was 
used to obtain a more precise resolution of the currents around the point of reversal.  
 
6.4.3 Results 
This section includes data from apical OHCs of P4-P7 C57b mouse cochleae, 7 of which were wild 
type and 9 were Asic1b-/-. Because of the higher calcium medium, some differences are apparent 
in MET current characteristics opposite to the differences found in low calcium medium in 
chapter 5. The average MET current size was smaller than usual: at -84 mV it was -0.309 ± 0.004 
nA in wild type and -0.307 ± 0.002 nA in Asic1b-/-, and the average resting MET current at -84 mV 
was 9.19 ± 0.04% of the maximum in wild type and 9.06 ± 0.11% in Asic1b-/-. These values of 
resting current are counterintuitively higher than in regular medium due to the smaller MET 
currents overall, but the smaller absolute resting current is evident in figure 6-3. The largest MET 
current recorded at -84 mV was -0.459 nA in wild type and -0.556 nA in Asic1b-/-. Average cell 
capacitance and access resistance data are only available for a select few recordings in  
Asic1b-/-. These values were 4.75 ± 0.047 pF capacitance (n = 2), and 4.75 ± 0.03 M access 
resistance (n = 2), well within the range of other values reported in this thesis. The solution in 
the fluid jet was set to high calcium to further avoid mixing of low and high calcium in the 





MET currents under superfusion of 100 mM Ca2+ solution from a total of 7 cells were recorded 
for the wild type mice, and 9 for the Asic1b-/- mice. An example MET current trace from each is 
shown in figure 6-3. MET current traces were averaged for each cell, and IV curves and their 
corresponding reversal potentials were calculated from the averaged traces (shown in  
figure 6-4). IV curves were analysed three ways to look for any sign of voltage-dependent effect: 
averaged, normalised to most depolarised current, and normalised to most hyperpolarised 
current.  In each case no obvious difference can be seen. The reversal potential under control 
solution is normally about -5 to +5 mV and is shifted upwards by about +20 mV in high calcium 
medium. Reversal potentials under high calcium in wild-type and knockout were statistically 
tested with an independent-samples t-test and were found to have p < 0.94, indicating that it is 
highly unlikely that there is a significant difference between the two samples. Genotyping was 
confirmed for all cells included in the data by Professor Shinya Ugawa. From these results it does 














These results indicate that ASIC1b does not modulate calcium sensitivity of the MET channel, 
and therefore further support the role of the TMCs as the pore-forming subunit. Nevertheless, 
even though ASIC1b does not appear to directly impact permeation, its location at the tips of 
the stereocilia suggests that it could still have some other role in the MET channel complex. 
Furthermore, as with the acid-sensitive currents, if other ASIC subunits are indeed present in 
hair cells then we cannot exclude that they could be functionally redundant and compensating 












Volume Regulated Anion Channels: an 
Alternative Route of Ototoxic Drug 





















Volume-regulated anion channels (VRACs) allow cells to respond to osmotic changes in their 
environment. They play an essential role in several fundamental cellular functions (König and 
Stauber, 2019), and are seemingly ubiquitous in mammalian cells (Stauber, 2015). VRACs are 
activated in response to swelling of the cell and allow efflux/influx of ions followed by water to 
produce a phenomenon called regulatory volume decrease (RVD) (Stauber, 2015). Like the MET 
channel, their unitary conductance is large (10-20 pS inward and 40-80 pS outward) (Hoffman 
et al., 2015; König and Stauber, 2019), and they can be permeated and blocked by a variety of 
molecules (Friard et al., 2017). Though intuitively they should be mechanically gated, it is 
presently unclear how VRACs are activated. Reports of VRAC-mediated RVD current through 
stimulation by cellular injection without changes in osmotic pressure are mixed (König and 
Stauber, 2019), and there are multiple reports of activation through various intracellular 
signalling pathways (Best and Brown, 2009; König and Stauber, 2019). Their molecular identity 
was proven just 6 six years ago and was found to be a complex of multiple subunits of the LRRC8 
family, most prominently LRRC8A (Voss et al., 2014).  
The role (or even existence!) of VRACs in hair cells has, to my knowledge, never been 
investigated. According to RNA-sequencing data made available through the gEAR portal 
(https://umgear.org/), both of the main VRAC subunits, LRRC8A and LRRC8D, are expressed 
throughout the organ of Corti, including by the hair cells. If VRACs are indeed active in OHCs, 
their non-selective permeability raises the possibility of VRAC-mediated ototoxin entry and may 
be relevant for some compounds that demonstrate behaviours in hair cells that are currently 
unexplained, like cisplatin. 
A potential avenue of interest in hair cells is that VRACs could be interacting with AGs. When 
AGs are first applied to OHCs numerous large membranous blebs appear on the apical surface 
of the cells (Goodyear et al., 2008; Osgood, 2020). These blebs can be fully endocytosed by the 
cell so long as AGs are soon washed out. This process can be blocked by the co-application of 
niflumic acid, which inhibits VRACs (Osgood, 2020). This suggests that VRACs are involved with 
cellular membrane repair following insult, and that AGs block this repair process leading to 
increased damage of the cells. Furthermore, AG loading is potentiated by inflammation (Koo et 
al., 2015) and osmotic stress (Osgood, 2020), further suggesting the possibility of AG permeation 




Cisplatin is a platinum-based anticancer drug that is also, unfortunately, ototoxic. At low doses 
it causes selective OHC death in a tonotopic gradient like that of the AGs. Abolishing 
mechanotransduction protects from cisplatin toxicity (Thomas et al., 2013), and several 
compounds that protect against AG-induced ototoxicity also protect against cisplatin, including 
ORC-13661, berbamine and d-turbocurarine (Kitcher, 2019). But the similarities between 
cisplatin and the AGs end here. In high doses, cisplatin produces damage to other cells of the 
organ of Corti, and its tonotopic gradient in ototoxicity is less pronounced than it is for 
gentamicin (Kitcher, 2019). The entry mechanism of cisplatin into hair cells has not yet been 
proven as it does not seem to block the MET channel, even in low calcium medium (figure 7-1). 
VRAC downregulation is connected to halting of apoptosis and is thought to be a mechanism for 
cisplatin resistance in tumour cells (Planells-Cases et al., 2015), indicating that cisplatin may 
enter cells through VRACs. Additionally, one study found that about 50% of cisplatin uptake in 
HEK cells depended on expression of the main LRRC8 subunits, and that uptake was increased 
by activation of VRACs (Planells-Cases et al., 2015). A later study found that overnight incubation 
with cisplatin profoundly potentiated the RVD current in HEK cells expressing VRACs, and this 
did not happen in cells without VRACs (Gradogna et al., 2017). 
There are other channels present in hair cell membranes that are permeable to AGs and possibly 
to cisplatin. For example, TRPA1 channels are permeable to GTTR when activated with an agonist 
that is present in the cochlea during oxidative stress (Stepanyan et al., 2011). Mechanically 
activated Piezo2 channels in the membrane have also been shown to interact with DHS, but with 
a lesser affinity than with the MET channel suggesting less permeation of AGs (Marcotti et al., 
2014; Beurg and Fettiplace, 2017). But research into the contributions of these channels to AG 
toxicity in hair cells has been relatively quiet recently due to the discovery that permeation 
through the MET channel was the primary route of AG entry (Marcotti et al., 2005).  
The recent observation regarding the effect of neomycin on membrane bleb endocytosis during 
hair cell repair (Osgood, 2020) brings VRACs into focus as a new avenue of research to potentially 
prevent ototoxicity. VRACs, if they are indeed present in OHCs, could be an alternative route of 
entry into hair cells for ototoxic drugs and could present a novel therapeutic target for 
otoprotection. To test whether VRACs are active in hair cells, I measured the macroscopic 
voltage-dependent current and resting current before and during osmotic stress on cultured 
OHCs via whole-cell patch-clamp. As a preliminary experiment, I then co-applied three 
compounds of potential interest (niflumic acid, neomycin, cisplatin) during osmotic stress to 







7.2 Methods and results 
The data in this section were acquired as described in chapter 2 except for a few differences that 
will be described here. No fluid jet was used as no MET currents were elicited. Two modified 
superfusion solutions were used. The base low osmolality solution contained (in mM): 88 NaCl, 
5.33 KCl, 5.55 Glucose, 0.33 NaH2PO4, 0.44 KH2PO4, 4.17 NaHCO3, 0.41 MgSO4, 0.49 MgCl2, 10 
HEPES, 1.2 CaCl2, and had an osmolality of 204 mOsmol kg-1. Into this was added 100 mM 
mannitol to bring the osmolality to 312 mOsmol kg-1. The first solution was used in the hypotonic 
condition and the second was used in the isotonic condition. The intracellular solution was the 
standard caesium-based solution described in chapter 2 to block most of the voltage-dependent 
basolateral K+ current of the OHCs. The recording protocol consisted of ten repeats of a 500 ms 
voltage ramp from -104 mV to +96 mV followed by a rest period of a further 500 ms at -84 mV. 
Recordings were digitally time-stamped, and repeats were averaged post-hoc. The resting 
current was calculated as the average of the final 250 ms of each averaged recording.  
Patched OHCs were locally perfused with control isotonic 100 mM mannitol solution for 1 to 5 
minutes. Voltage ramps were applied every 10-30 seconds for the duration of the experiment. 
During this time no changes in cell morphology, resting current, or voltage-dependent current 
were observed. The solution was then switched to the hypotonic solution of 0 mM mannitol. All 
cells in the field of view visibly swelled in size within approximately 1 minute (figure 7-2). The 
resting membrane current dropped significantly, and a rectifying current with a reversal 
potential of approximately -5 to -10 mV was observed during voltage ramps (examples shown 
in figure 7-3, figure 7-4). These changes were usually followed shortly by cell death; all but one 
patched cell exploded after less than 2 minutes in hypotonic solution. This cell was recovered by 
switching back to isotonic solution. The resting membrane current following recovery returned 
halfway to the level of the control current, and the currents during voltage ramps decreased 
back to control. The currents from this cell are shown in figure 7-4. Due to the close match of 
the behaviour of these currents with the descriptions in published literature, we concluded that 
these were indeed VRAC-mediated RVD currents in OHCs. 
VRAC currents were elicited from a total of 5 apical OHCs of P2+1 and P2+2 cultured CD-1 mouse 
cochleae. The average peak VRAC current size (with current at rest subtracted) at -104 mV was 
–158.15 ± 88.08 pA and at +96 mv was 149.79 ± 88.98 pA. The average resting current before 
osmotic stress was -25.09 ± 9.85 mV and during osmotic stress the resting current peaked on 
average at -133.15 ± 62.34 mV. The largest VRAC current recorded at -104 mV was -285.16 pA 
and at +96 mV was 267.64 pA. The average cell capacitance was 5.6 ± 0.03 pF and access 
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resistance was 5.6 ± 0.09 M. Currents from an additional 2 cells were recorded but these were 
likely patched too quickly after return to superfusion of isotonic solution from the previous cells 
as on analysis they appeared to already have large rectifying VRAC currents that did not further 
increase when changing to hypotonic solution. A comparison with isotonic currents could 
therefore not be made and these cells were excluded from analysis. Some of this effect to a 
lesser extreme is visible in panel A of figure 7-4. 
Further to this, three compounds were each co-applied to wild type cells during osmotic stress: 
niflumic acid, neomycin, and cisplatin. The results are shown in figure 7-5. Each graph includes 
the same five control cells as previously described, and three cells with drugs applied. Though 
the results are preliminary, all three compounds exhibited some degree of block of the VRAC 
current. The strongest block was seen by neomycin, bearing mind that a relatively high 
concentration was used. Intriguingly, some degree of block by cisplatin can be seen in panel C, 
though only one cell lasted for long enough to be able to see this effect and it was not as strong 
as either niflumic acid or neomycin. This delay in activation of VRAC currents measured at -100 
mV indicates that all three compounds may block inward VRAC currents. No block or delay in 
activation was seen in currents at +100 mV measured over the same time period (data not 


















These data show that VRAC currents do indeed exist in OHCs as they match every published 
description of the VRAC-mediated RVD current, including the characteristic outward 
rectification at positive potentials evident in panel B of figure 7-3 and more prominently in  
panel A of figure 7-4 (Planells-Cases et al., 2015; Hoffman et al., 2015; Friard et al., 2017). 
Additionally, my results with neomycin and cisplatin presented in figure 7-5 show that these 
compounds may interact with VRACs and may permeate through them.  
It should be noted that in these experiments I did not control for the potential contribution of 
other mechanically sensitive channels in the hair cell membrane such as Piezo2 (Marcotti et al., 
2014; Beurg and Fettiplace, 2017). Though the effect of Piezo2 activity on these currents cannot 
be excluded, the block of the VRAC current by niflumic acid (a Cl- channel blocker which should 
not interact with Piezo2) shown in panel A of figure 7-5 indicates that these currents are mostly 
due to VRAC activity. Future experiments could determine whether application of a Piezo 
channel blocker such as GsMTx4 affects the characteristics of the VRAC currents I have 
presented, and therefore whether Piezo2 is activated by osmotic membrane stretch in OHCs. 
The block by neomycin evident in panel B of figure 7-5 is strongly indicative of an interaction 
between neomycin and the VRACs. The biophysical mechanism of this block is yet to be 
determined: whether it is like the MET channel block by AGs (pore block of the permeation 
path), or whether it is intracellularly blocking activation of the VRACs. Either way, relieving this 
block could prevent the disruption of the RVD process and therefore protect hair cells from some 
of the ototoxic effects of neomycin. This presents a novel potential therapeutic target for 
research in otoprotection.  
Cisplatin has long been a mysterious compound due its unusual behaviour in hair cells which at 
times mimics that of the behaviour of AGs and at times does not (Thomas et al., 2013; Kitcher, 
2019). Given the lack of block of the MET current by cisplatin (figure 7-1), my preliminary data 
showing block of the VRAC current by cisplatin (figure 7-5, panel C) raises the possibility that 
cisplatin may interact with the MET channel through a different mechanism than with the 
VRACs. If cisplatin were to permeate through both the MET channels and the VRACs, this would 
account for many aspects of its behaviour: the reduced gradient in ototoxicity, the protection 
by MET channel blockers (Kitcher, 2019) and loss of mechanotransduction (Thomas et al., 2013), 
and the potentiation of uptake following VRAC activation (Planells-Cases et al., 2015). Further 
experiments to conclusively determine whether cisplatin does indeed block VRAC currents in 

























8.1 Differential permeation of ototoxic drugs 
In this thesis, I investigated the permeation characteristics of five ototoxic compounds in several 
different conditions through the MET channel of mouse OHCs. These included: gentamicin, 
kanamycin, amikacin, GTTR, and cisplatin. In chapter 3, I found that in conditions relevant to 
ototoxicity in vitro, the entry rate of the native AGs correlated with their respective degree of 
toxicity. In chapter 4, I found that GTTR, though it saturates the channel at a far lower rate than 
native gentamicin, permeates at a similar rate at low concentrations commonly used for in vitro 
uptake experiments, and is therefore a suitable indicator of gentamicin entry into hair cells. In 
chapter 5, I investigated the effects of driving force on gentamicin permeation and found that 
the differences set up by the endolymphatic medium and the endocochlear potential will 
summate to an increased permeation rate in vivo compared to in vitro. I also predicted that 
mature basal cells would have a 6-fold higher rate of gentamicin permeation than mature apical 
cells in a live cochlea, likely contributing to the frequently reported loss of high frequency 
hearing by patients receiving AG treatment. Additionally, I found that the entry rates of all drugs 
were lower in apical cells than in basal cells, which corresponds to their gradient in sensitivity 
and further supports the idea of the degree of toxicity being related to entry rate through the 
MET channel. Finally, in chapter 7 I found that cisplatin does not block the MET channel even 
with the removal of calcium competition for the binding site, and I discussed alternative 
methods by which it (and potentially the AGs) may be entering into hair cells, for example 
through VRACs.  
These results demonstrate the relationship between permeation rate and ototoxicity of AGs and 
strongly support the notion of targeting entry of drugs into hair cells through the MET channel 
as a main priority for preventing ototoxicity in patients receiving acute and chronic AG 
treatment. A deeper understanding of the factors that lead to differential permeation of AGs 
through the MET channel, perhaps through dynamic molecular simulations using recent 
structural data of the permeation pore, could lead to design of novel AGs that are less permeant 
and therefore less ototoxic. Alternatively, understanding what makes molecules permeant or 
not could guide the search for selective non-permeant competitive channel blockers that will 





8.1.1 Observation on half-block and entry rate  
An interesting observation throughout these experiments is that the relationship between 
permeation rate and half blocking concentration (KD) was not always straightforward. For 
gentamicin, generally conditions that caused stronger block of the channel corresponded to a 
higher entry rate and vice versa. For example, the KD of gentamicin in low calcium medium was 
lower than in regular medium and its entry rate higher, whereas the KD in mature cells was 
higher than in neonatal cells and the entry rate lower. This trend did not hold across different 
drugs however, as the KD of amikacin was in between that of gentamicin and kanamycin, and 
yet at certain concentrations the entry rate of kanamycin was between that of gentamicin and 
amikacin. Furthermore, the KD of GTTR was far lower than native gentamicin, but its entry rate 
at high concentrations was much lower due to saturation of the channel by the large size of the 
molecule. Finally, for every drug tested no difference was evident in between the KD of apical 
and basal channels and yet large differences in permeation were found in every case.  
Though the KD is not always a predictor of the entry rate, the span of the lower and upper bounds 
of the dose response curves does seem to relate to the spread of the entry rates over voltage 
and concentration, in other words the steepness of the saturation of permeation.  
 
8.2 Tonotopic gradient in permeation of neonatal 
OHCs 
All together the data for the three AGs and GTTR suggest that the cause of the well-reported 
tonotopic gradients in ototoxicity and in fluorescence uptake observed in neonatal cochlear 
cultures is rooted in differences in permeation of the drugs through the apical and basal MET 
channels. The reason for this differential permeation is not straightforward and is related to 
significant controversy in the literature of the last few years surrounding the expression profile 
of the MET channel and its single channel conductance. It may be tempting to simply take the 
larger total current size and channel number of basal cells compared to apical cells as an 
indication of higher permeation, but all results are normalised for current size and presented for 
a single open channel. Furthermore, the larger size of currents in mature OHCs and their lower 
entry rate show this not to be the case. There are currently two main models by which graded 
permeation might be achieved by the channel. Simply put, the first is a gradient in pore 
diameter, and the second is a gradient in pore number per cell. 
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The situation is further complicated by a gradient in the expression of TMC1 and TMC2 in the 
neonatal cochlea. Because my results were obtained in wild type mice with uncontrolled 
expression of the two TMC isoforms, I cannot directly comment on the role of these two proteins 
in permeation. However, I can provide some speculative insight based on evidence in the 
literature and the resulting predictions for what the behaviour of these two isoforms would be 
and compare this with my results. Furthermore, the question of single channel conductance in 
our model of permeation becomes complicated by the implications of recent evidence showing 
that TMC1 assembles as a dimer (Pan et al., 2018; Ballesteros et al., 2018), and that the MET 
channel complex may contain multiple TMC dimers per complex (Beurg et al., 2018). I will 
address both questions as they relate to my results and our model of MET channel permeation.  
 
8.2.1 Permeation of TMC1 versus TMC2 
At the age in which my cultures are made (P2) it is thought that the basal cells will express mostly 
TMC1 while the apical cells will only express TMC2 (Kurima et al., 2015). However, viewing my 
results in the context of previous experiments comparing the permeation of DHS through the 
MET channel in Tmc2-/- mice suggests that my results are not indicative of a shift simply in the 
expression levels of the TMCs. These previous results found a lower entry rate in apical OHCs of 
Tmc2-/- (TMC1 only) mice (Corns et al., 2017) whereas according to my results the basal OHCs 
(which express more TMC1) had a higher entry rate. Furthermore, this previous study found a 
difference in the KD between Tmc2-/- and wild type cells, but I did not observe this between apical 
and basal cells of neonatal cultures for any drug. I did however see a difference in KD between 
neonatal apical cells and mature apical cells which should reflect the same shift in TMC 
expression as the Tmc2-/- mice, though the shift I saw was in the opposite direction—the reason 
for this is unclear. The reason for the lack of a shift in KD between apical and basal neonatal cells 
is also unclear. Taken together, these results indicate that the differences in permeation I have 
presented probably reflect a gradient in the permeation of TMC1 which corresponds to its 
gradient in single channel conductance, and not simply to a difference in between TMC1 and 
TMC2. In other words, the mechanism setting up the gradient in TMC1 conductance is already 
present at the early stages of TMC1 expression in the neonatal cochlea. In fact, the observation 
that apical and basal MET channels of the neonatal cochlea had the same KD for all drugs tested 
suggests an intentional developmental balance in between TMC1 and TMC2, though evidence 
for this is currently lacking as Tmc2-/- mutants show no deleterious effects during development 
(Kawashima et al., 2011; Corns et al., 2017).  
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8.2.2 The definition of a single MET channel 
Understanding the difference in permeation between apical and basal cells in my results 
requires probing the definition of a single channel in our model, which has become fraught with 
controversy. Ordinarily a single channel would be taken as a single pore through which ions flow. 
However, the unique properties of the MET channel, specifically its tight mechanical gating, 
render the story more complicated. It has long been thought that multiple channels may be 
cooperatively gated by the tip link (Beurg et al., 2006; Gianoli et al., 2017), making recording 
true single channel activity difficult. Furthermore, recent evidence by the Fettiplace group 
suggests that the MET channel complex may comprise multiple TMC1 inserts with what they 
term variable conductance states, which they observe in discrete multiples of approximately  
50 pS (Beurg et al., 2018). This is based on measures of single channel conductance using BAPTA 
to break tip links and recording rare instances in which they observe discrete single channel-like 
currents. While interesting, these methods are questionable, and there could be alternative 
explanations such as residual cooperative gating of channels that are intricately linked together. 
They also further suggest that the number of TMC1 pore insertions varies from apex to base 
with ~20 per basal channel and 8 per apical channel, citing observation of multiple fluorescently 
tagged TMC molecules per tip link insertion (Beurg et al., 2018).  
Our two-barrier one-binding site model suggests that the differences in permeation between 
the apex and the base are due to differences in the height of the energy barriers and position of 
the binding site within the channel pore. The simplest interpretation of these results is that basal 
channels have a larger pore diameter than apical channels. This variation in shape could be due 
to posttranslational phosphorylation (Pan et al., 2018; Corey et al., 2019) or perhaps variable tip 
link tensioning deforming the membrane or channel itself (Powers et al., 2012; Reichenbach and 
Hudsepth, 2014; Tobin et al., 2019). However, given the recent evidence from the Fettiplace 
group our pore diameter hypothesis must be called into question. While discrete levels of  
single-channel conductance could perfectly agree with our model, the idea that the number of 
TMC1 insertion sites changes per single channel complex does not. Though our model is certainly 
capable of detecting differences in permeation, how it would account for multiple cooperatively 
gated pores is uncertain. The model has a finite number of parameters and varies these to fit 
the data that it is given. It is possible that in our model multiple distinct permeation pores per 
“single channel complex” could appear as an individual channel which the model interprets as 
having a larger conductance. However, I would not exclude the possibility that a variable number 
of TMC1 molecules around a central attachment point could also alter their conformation. There 
could be multiple factors influencing the gradient in conductance.   
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8.3 MET channel pore modelling and its future 
The future of this field is without doubt in combining multiple modelling approaches, including 
structural homology modelling of the pore-forming subunit with experimental modelling of 
molecule permeation, particularly using genetically modified TMCs. Together these approaches 
can further elucidate the biokinetics of the MET channel, which in turn can help us to understand 
how to prevent ototoxicity.   
Specifically, it would be interesting to determine the exact roles of each of the charged pore-
lining residues in the permeation of the channel. By selectively modifying each of these residues 
we could determine the identity of the interaction sites and build a dynamic molecular 
simulation of how drugs permeate through the MET channel pore. This approach could aid in 
preventing drug permeation either by refining the search for non-permeant channel blockers, 
or by redesigning AGs so they are still as bactericidal but less permeant through the MET 
channel. It could also help elucidate whether the TMC1 pore can distort in shape between the 
apex and base either through differences in gating, in assembly around a central unit, or in 
phosphorylation. Conversely, it could determine whether the differences in single channel 
conductance are in fact due to cooperatively-gated multiples of the same pore with no 
additional conformational changes. Furthermore, it would be interesting to discover the exact 
roles of the other potential members of the MET channel complex: CIB2, ASIC1b, LHFPL5, and 
TMIE.  
These could clarify how the MET channel complex is assembled, whether it is indeed comprised 
of multiple discrete pores beyond the dimer that is expected, and how it is gated so precisely.  
A new structural model that includes each of these accessories to the MET channel complex 
could very well be essential to understanding the graded permeation of the TMC1 pore.  
 
8.5 Final remarks 
In this thesis I hope to have contributed to the understanding of the complicated but beautiful 
permeation path of the MET channel, how it is related to ototoxicity, and what future 
experiments could be done to further address these questions. I hope to have provided a 
roadmap for approaches to preventing the permeation of essential life-saving drugs into 
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